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ABSTRACT 
Evaluation of Predicted and Observed Data on 
Biotransformation of Twenty-Nine Trace Organic Chemicals  
Maria Luisa Carvalho Bertolini 
Trace organic chemicals present in household products, pesticides, pharmaceuticals and 
personal care products may have adverse ecotoxicological effects once they are released to the 
environment. These chemicals are usually transported with the sewage to wastewater 
treatment facilities, where they might be attenuated depending on the degree of treatment 
applied prior to discharge to receiving streams. This study evaluates the removal performance of 
29 trace organic compounds during two different activated sludge treatment systems. 
Predominant attenuation processes such as biotransformation and sorption for the target 
compounds were identified. Biotransformation rate constants determined in this study were 
used to assess removal of compounds from other treatment plants with similar operational 
conditions, using data gathered from the literature. The commercial software Catalogic was 
applied to predict environmental fate of chemicals. The software program consisted of four 
models able to simulate molecular transformations and to generate degradation trees. In order 
to assess the accuracy of this program in predicting biotransformation, one biodegradation 
model is used to contrast predicted degradation pathway with metabolic pathways reported in 
the literature. The predicted outcome was correct for more than 40 percent of the 29 targeted 
substances, while 38 percent of the chemicals exhibited some degree of lower agreement 
between predicted and observed pathways. Percent removal data determined for the two 
treatment facilities was compared with transformation probability output from Catalogic. About 
80 percent of the 29 compounds exhibited a good correlation between probability of 
transformation of the parent compound and percent removal data from the two treatment 
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plants (R2 = 0.82 and 0.9). Based upon findings for 29 trace organic chemicals regarding removal 
during activated sludge treatment, attacked fragments present in their structures, predicted 
data from Catalogic, and peer-reviewed pathways,  possible indicator compounds capable of 
representing the removal of other compounds based on similar structures were identified. In 
conclusion, nine among the 29 select compounds were grouped into two categories showing 
similarities between removal, probability of transformation and attacked fragments. If more 
chemicals are evaluated, this approach could be useful to establish other indicator compounds 
based on identification of groups of chemicals with similar fate, properties, and structures. 
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I. INTRODUCTION 
In the past decade, several studies have raised concern about the presence and potential 
adverse health effects of trace organic chemicals in potable water supplies (Kruawal, Sacher et 
al. 2005; Kim, Cho et al. 2007; Barnes, Kolpin et al. 2008; Focazio, Kolpin et al. 2008; Mompelat, 
Le Bot et al. 2009; Watkinson, Murby et al. 2009; Kumar and Xagoraraki 2010; Loos, Locoro et al. 
2010; Metcalfe, Chu et al. 2010; Muñoz, Milà-i-Canals et al. 2010; Kleywegt, Pileggi et al. 2011). 
These chemicals of emerging concern, both synthetic and natural organic compounds, comprise 
several pesticides, pharmaceuticals, personal care products and household chemicals. 
Eventually, they are transported with the sewage to wastewater treatment plants (WWTP). 
Chemical constituents resistant to biodegradation and sorption during conventional wastewater 
treatment are expected to be present in the discharged effluent and can accumulate into stream 
beds and drinking water reservoirs, such as rivers, lakes, and aquifers.  
At first sight, those products should not affect human health in a great extent, once they are 
mainly made for human consumption and use. However, most of them are widely used in great 
quantities and usually their application is not curbed by laws. Also, for trace organic chemicals 
(TOrC) of emerging concern limited information on their toxicity is available. Once released into 
the environment, some of these substances can persist and accumulate in aquatic life in 
quantities able to adversely affect organisms (Joss, Andersen et al. 2004; Joss, Zabczynski et al. 
2006; Caliman and Gavrilescu 2009). For this reasons, it is important to evaluate to which extent 
treatment systems are able to eliminate TOrCs. 
The need to analyze and predict removal performance of a wastewater treatment facility 
without carrying out expensive laboratory analysis or fate studies has motivated the 
development of several programs, routines and software packages using quantitative structure 
property relationship (QSPR) to predict removal of chemicals under different conditions (van 
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Leeuwen, Vermeire et al. 2007). If those programs are relatively accurate to quantify 
biotransformation given the characteristics of the treatment process, they can be a very useful 
tool to assess the performance of a facility without the need of measuring the removal of the 
many contaminants. 
Catalogic version 5.11.1 acquired from the company OASIS (Bulgaria) was the software applied 
in this study. This software package is able to predict environmental fate of chemicals based on 
models able to simulate molecular transformations and generate degradation pathways. 
Chemicals can be biodegraded all the way to CO2 and H2O (mineralization) or they can be 
transformed in a metabolite, which may represent a more or less toxic and persistent substance 
(Farré, Pérez et al. 2008). It is important to understand this concept and keep in mind that 
percent removal and biotransformation rates just consider the first modification of a parent 
compound, thus products of this modification might still end up in the environment through 
discharge of sludge or treated wastewater. In this context, if degradation pathways and 
information on quantities of metabolites predicted by Catalogic software roughly represent the 
fate of the parent compound in a conventional WWTP, information on recalcitrant metabolites 
would be available without the need to experimentally measure these substances. 
This study assessed the accuracy of Catalogic models in predicting biotransformation for 29 
selected TOrCs that represent different classes of chemicals, with also very diverse removal 
efficiencies during activated sludge treatment.  It also correlated biotransformation rate 
constants of selected TOrC with the presence of fragments in its chemical structure. Predicted 
and observed information on removal of TOrCs from conventional WWTPs were linked to 
fragments present in their structures, in order to identify possible indicator compounds capable 
of representing the removal of other compounds based on similar structures.  
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II. LITERATURE REVIEW 
2.1 Trace Organic Compounds (TOrCs) in the Environment 
The presence of trace organic chemicals has been reported in potable water supplies of many 
countries (Stackelberg, Furlong et al. 2004; Kruawal, Sacher et al. 2005; Mompelat, Le Bot et al. 
2009; Watkinson, Murby et al. 2009; Kumar and Xagoraraki 2010; Maeng, Ameda et al. 2010; 
Muñoz, Milà-i-Canals et al. 2010; Kleywegt, Pileggi et al. 2011). Some of these compounds are 
often called “emerging” contaminants, which can be defined as chemicals recently detected in 
the environment in levels that may cause a yet unclear toxicological effects to human health and 
environment (NORMAN Project 6th Framework Programme and The U.S. Geological Survey, 
Toxic Substances Hydrology Program, Research Projects, Emerging Contaminants1). Classes of 
emerging substances include pesticides, pharmaceuticals and personal care products (PPCPs), 
and household chemicals. 
Pharmaceuticals and personal care products are continuously released into the environment; 
some of them constituting a potential source of endocrine disruption (Daughton and Ternes 
1999). Endocrine disrupting compounds (EDCs) include, alongside the natural hormones, several 
additives used in high amounts in drugs, domestic and industrial cleaning agents, fire-
retardants, some pesticides and heavy metals (Caliman and Gavrilescu 2009). Molecular classes 
of EDCs are highly variable, from chlorinated pesticides, phthalates and phenols to natural and 
synthetic hormones (Clouzot, Marrot et al. 2008).  
Pharmaceutical compounds are used in treatment of humans and animals diseases and 
imparities. After ingestion, the native form of the chemical and/or its metabolite compounds are 
excreted via urine and faeces (Mompelat, Le Bot et al. 2009). 
                                                          
1
 Websites are http://toxics.usgs.gov/regional/emc/ and http://www.norman-network.com/. 
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Once solid residues and sewage treated to various extents are discharged into the environment, 
the chemicals present in these effluents can end up in stream beds and drinking water 
reservoirs, such as rivers, lakes, and aquifers. Hormonally active compounds present in sewage 
sludge and animal manure can contaminate watersheds through surface runoff or infiltration, if 
applied to agricultural fields for fertilization purposes (Drewes and Shore 2001). Groundwater 
can also be impacted by fertilizers, pesticides and other chemicals through artificial 
groundwater recharge, infiltration of rain and irrigation water, and contaminated surface water 
percolation, which will carry these leached compounds into underlying aquifers (Drewes and 
Shore 2001). 
The presence of TOrCs in the environment represents a concern for several reasons. Firstly, 
ecotoxicological effects of some of these chemicals are not very well understood, leading to an 
absence of regulations restricting their use and applications. Secondly, some of these chemicals 
are consumed in great quantities, and can accumulate and persist in the environment in 
concentrations able to adversely affect organisms. 
Among the classes of TOrCs, pharmaceuticals are likely to bioaccumulate because these 
molecules are usually lipophilic and persistent, so that they can permeate cell membranes and 
remain in the organism long enough to result in a therapeutic effect (Halling-Sørensen, Nors 
Nielsen et al. 1998). They may also represent a distress for aquatic and terrestrial ecosystems 
once these substances are designed to be biological active. Alternatively, chemicals that are not 
intended to human consumption, such as personal care products, flame retardants and 
pesticides, may have potent toxic effects in human health, but the consequences of their 
ingestion are even less comprehended than medical substances (Stackelberg, Furlong et al. 
2004). For the reasons presented above, it is important to evaluate the fate of TOrCs during 
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wastewater treatment, so that they are eliminated from treated effluent and do not reach 
drinking water supplies. 
 
2.2 Physicochemical Properties of TOrCs and Fate on Conventional WWTP 
Trace organic compounds comprise diverse chemical structures and functions. Their removal 
during conventional wastewater treatment is as diverse as their molecular structures. For 
instance, chemicals from the same class (synthetic and natural hormones) can exhibit different 
biodegradation behavior (Clouzot, Marrot et al. 2008). 
TOrCs selected in this study represent different classes of chemicals (Appendix A) that also 
represent different removal efficiencies during activated sludge treatment. Bioactive molecules 
in PPCPs, pesticides and household chemicals, as well as their metabolites, can represent a 
health concern once released into the environment (Combalbert and Hernandez-Raquet 2010). 
Activated sludge treatment has been chosen in this study because it is the most common 
treatment system currently deployed during conventional wastewater treatment. 
Physicochemical properties of TOrCs determine biodegradation and accumulation of these 
chemicals, and are linked to removal mechanism occurring during wastewater treatment, 
including volatilization, sorption to solid particles and biological and chemical transformation 
(Suarez, Carballa et al. 2009). Table 2.1 present the set of TOrCs selected for this study and their 
physicochemical properties. Please, refer to Appendix B for CAS numbers, molecular formulas, 
and structures. 
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Table 2.1 – List of emerging compounds considered in this study and their physicochemical 
properties 
Compounds Physicochemical Properties 
 
Molecular Weight 
(g/mol) 
Water solubility 
(mg/L) 
logKow pKa 
Acetaminophen 151.2 1.40x10
4
 0.46 9.38 
Amitriptyline hydrochloride
a
 313.9 10.8 est 2.18 est na 
Androstenedione
a
 286.4 57.8 2.75 na 
Androsterone
a
 290.4 12 3.69 na 
Atenolol 266.3 1.33x10
4
 0.16 9.2 
Atorvastatin
a
 558.7 1.12x10
-3
 est 6.36 est na 
Bisphenol A 228.3 120 3.32 9.6 and 10.2 
Caffeine 194.2 2.16x10
4
 -0.07 10.4 
Carbamazepine 236.3 18 2.45 13.9 
DEET 191.3 912 est 2.18 0.7 est 
Diazepam 284.7 50 2.82 3.4 
Diclofenac 296.2 2.37 4.51 4.15 
Dilantin
a
 252.3 32 2.47 8.33 
Estradiol (17β) 272.4 3.6 4.01 10.4 
Estriol 288.4
a
 441 est
a
 2.45
a
 10.4 est
b
 
Estrone 270.4 30 3.13 10.4 
Ethynylestradiol (17α) 296.4 11.3 3.67 10.4 
Gemfibrozil 250.3 10.9
a
 4.77 est 4.42 
Ibuprofen 206.3 21 3.97 4.91 
Meprobamate 218.3
a
 4700
a
 0.7
a
 10.9 est
b
 
Naproxen 230.3 15.9 3.18 4.15 
Phenylphenol
a
 170.2 700 3.09 9.97 
Primidone 218.3 500 0.91 11.1 and 12.2 
Risperidone
a
 410.5 2.16 est 3.49 est 9.57 est 
Sulfamethoxazole 253.3 610 0.89 5.5 
TCEP 285.5 7000 1.44 na 
Testosterone 288.4 23.4 3.32 na 
Triclosan 289.5 10 4.76 7.98 est 
Trimethoprim 290.3 400 0.91 7.12 
Physicochemical properties from Snyder et al. (2009), unless otherwise stated. 
a http://www.syrres.com/what-we-do/databaseforms.aspx?id=386 
b (Drewes, Sedlak et al. 2008)  
16 
 
Sorption potential of TOrCs includes absorption and adsorption mechanisms, which can be 
described as a function of both hydrophobic character  (Gulkowska, Leung et al. 2008) and 
acidity (Suarez, Carballa et al. 2009) of these compounds. Non-specific interactions between 
chemicals and sludge contributing to removal due to sorption can be described by Kow values, as 
long as molecules are present in their neutral stage. If the chemical is charged, it may also 
interact with charged moieties on solid particles (Maurer, Escher et al. 2007).  
The parameter log Kow can be used to predict partitioning behavior of chemicals and could serve 
as a predictor for adsorption. During activated sludge treatment, aliphatic and aromatic groups 
present in dissolved chemicals are able to interact with lipophilic cell membranes of 
microorganism, mineral oils, greases and other fat components of the mixed liquor suspended 
solids (Suarez, Carballa et al. 2009). If this interaction is strong enough, the chemical adheres to 
the sludge and is removed from the aqueous fraction.  
It is generally assumed that most neutral and anionic compounds with a low log Kow (lower than 
2.5) have low sorption potential (Caliman and Gavrilescu 2009), thus percentage removal on 
secondary systems for these compounds is assumed to occur by degradation. These compounds 
are usually polar and hydrophilic, characteristics driving water solubility. Oppositely, values of 
log Kow higher than 4.0 indicates an increase of sorption potential for neutral substances 
(Stevens-Garmon, Drewes et al. 2011), which are usually more hydrophobic, easily removed 
during wastewater treatment, but also capable to bioaccumulate in the environment.  For 
instance, the hydrophilic nature of carbamazepine and its chemical stability is responsible for 
the low removal efficiencies of this compound during activated sludge treatment (Nakada, 
Tanishima et al. 2006). 
As mentioned before, chemicals positively charged can adhere or bind to negatively charged 
moieties of the sludge (Van der Waals-type interactions) and be removed by another sorption 
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mechanism: adsorption. This phenomenon happens if a substance is likely to be ionized or 
dissociated in the aqueous phase, and the likelihood can be characterized by the dissociation 
constant (pKa) (Suarez, Carballa et al. 2009). For instance, positively charged molecules, such as 
trimethoprim, are more likely to adsorb than anionic species of acidic compounds, such as 
diazepam, diclofenac, gemfibrozil and naproxen. 
The molecular weight can also influence removal. While low-molecular weight compounds are 
usually more prone to volatilization (Yu, Bouwer et al. 2006), high-molecular weight ones are 
not able to be transferred across the membrane to the cytoplasm of bacteria, and thus do not 
react with intracellular enzymes, reducing removal by biodegradation (van Leeuwen, Vermeire 
et al. 2007). 
Removal of TOrCs is also related to the ability of microorganisms in activated sludge to attack 
fragments or functional groups of the molecule, thus transforming the parent compound. 
Collecting samples and measuring removal data for all emerging contaminants of concern are 
neither feasible nor desired. One way to avoid demanding experimental analysis is to optimize 
operational conditions of a WWTP to a level that guarantees elimination of most emerging 
pollutants. Some programs are able to predict the fate of a compound for a certain treatment 
plant if operational and fate parameters (e.g. biotransformation rate constant, sorption 
coefficients, SRT, HRT, etc.) are available (Seth, Webster et al. 2008). Other programs can assess 
biodegradability of organic compounds providing, for example, biotransformation rate constants 
and BOD as end points. These routines are based on QSPR models using very diverse molecular 
descriptors (Drewes, Dickenson et al. 2009). 
Qualitative structure property relationship models have also been developed, and they 
generally provide the tendency of an organic compound to biodegrade or not (Dickenson, 
Drewes et al. 2010). One example is the Biodegradability Probability Program (BIOWIN), part of 
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the EPI Suite 4.0 software package owned by the United States Environment Protection Agency. 
This program consists of seven degradation models, six of them using qualitative data from tests 
under aerobic conditions. These models are based on the group contribution method, in which 
molecules are described as a combination of functional groups or structural fragments, and each 
fragment either facilitates or hinders biodegradation (Boethling, Howard et al. 1994). The 
applicability of these models in the present study is limited because the predicted qualitative 
data cannot be used to estimate quantitative data, such as percent removal or 
biotransformation rate constants. Besides, biodegradability is highly affected by environmental 
conditions, and controlled laboratory experiments used to derive these models may not 
represent the conditions where biodegradation wants to be predicted, i.e. wastewater 
treatment (Drewes, Dickenson et al. 2009). 
The software applied in this study combines information from the biodegradability OECD 
Japanese MITI Database (also used in BIOWIN 5 and 6 models) with a transformation dictionary 
including more than 600 reactions to predict environmental fate of chemicals. The models of 
Catalogic software simulate molecular alterations based on likelihood of functional groups to 
undergo transformation, and ultimately generate degradation pathways. 
This study had evaluated the applicability of this software in predicting removal of the 29 select 
TOrCs during activated sludge treatment. In order to assess transformation efficiency of these 
compounds, another purpose of this work is to identify a small set of indicator compounds that 
can represent several other TOrCs from different classes but with similar properties.  
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III. EXPERIMENTAL APPROACH 
3.1 Description of Operational Conditions to Determine kbio and Percent Removal 
Experimental data from controlled biodegradation studies for selected TOrC were kindly 
provided by Dr. Eric Dickenson, Colorado School of Mines and comprises biotransformation rate 
constants and percentage removal of 29 compounds using mixed liquor samples from two 
different activated sludge systems. These systems represent a full-scale municipal wastewater 
treatment plant and a laboratory-scale activated sludge reactor system both located in 
Colorado. The Denver Metro Wastewater Reclamation District is operating a full-scale plant and 
its secondary treatment consists of a conventional nitrifying activated sludge process, with a SRT 
of 5 days and an HRT of approximately 8 hours. The second system, CSM’s Mines Park, is a 
laboratory scale flow-through nitrifying/partially denitrifying activated sludge process, with a 
SRT of 11 days and an HRT of approximately 24 hours.  
To determine the percent removal of TOrCs by these treatment systems, grab samples were 
collected at the same time from the influent and effluent of the activated sludge treatment 
tank, not considering the hydraulic residence time. Denver Metro’s activated sludge was 
considered acclimated to the chemicals targeted in this study due to their presence in the 
wastewater influent. For the Mines Park system, the lab-scale system was exposed to the target 
chemicals during 4 months prior to this study by continuously spiking a standard solution 
containing TOrCs. 
The chemical content present on the solid phase (i.e. activated sludge) was not measured, so 
the percent removal determined for the compounds in both treatment plants are likely due to a 
combination of sorption and biodegradation. However, the rate constant kbio does consider and 
discount sorption effects, and was calculated according to Equation 3.1 (Dickenson, Drewes et 
al. 2010), 
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where S is the soluble compound concentration (ng L-1), t is time (days), kbio is the 
biotransformation rate constant (L gSS
-1d-1), Xss is the mixed liquor suspended solid concentration 
(gSS L
-1), and Kd is the sorption coefficient of the activated sludge (L gSS
-1). 
To determine individual biotransformation rate constants kbio, controlled biotransformation 
experiments were performed in triplicate, with activated sludge from the two treatment 
systems, separately. The setup consisted of amber glass reactors maintained at ambient 
temperature (19C), constantly stirred and aerated, with a dissolved oxygen concentration 
kept between 2 to 4 mg/L. Abiotic controls were also carried out in parallel and biological 
inactivation was performed with a mixture of sodium azide (5%) and nickel/barium chloride 
(5mM). 
The water quality for the Denver Metro nitrification system and the nitrification/denitrification 
system at Mines Park are summarized in Table 3.1. Ammonia and nitrate levels reported were 
measured in MLSS samples collected from both biotransformation experiments initially, and 
after 24 hours. 
Table 3.1 – Water quality parameters measured during biotransformation experiments 
(adapted from Dickenson, Drewes et al. 2010) 
Sample Time pH COD 
(mg/L) 
Nitrate 
(mg/L NO3-N) 
Ammonia 
(mg/L NH3-N) 
MLSS 
(mg/L) 
TOC 
(mg/L) 
Denver Metro       
Initial 7.8 11 0.3 0.27 2595 11.8 
24 hours 8.1 26 16.6 0.25 1900 15.4 
CSM Mines Park       
Initial 7.9 27 14.8 0.54 1472 7.7 
24 hours 8.3 25 18.4 0.58 1308 7.2 
5 days 8.4 74 59 0.31 nd 6.6 
nd: not determined 
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3.2 Boundary Conditions for Published Transformation Pathways 
For comparison purposes, metabolic pathways for each of the 29 chemicals were compiled from 
the literature. During this literature review, preference was given to the University of Minnesota 
– Biocatalysis and Biodegradation Database (UM-BBD), because it compiles published, scientific, 
relevant data and presents all the available information for a single compound assembled in one 
biodegradation pathway (Gao, Ellis et al. 2010). For the substances not listed in this database, 
metabolic pathways were extracted from published papers that propose a certain pathway 
based on observed metabolites determined experimentally, most commonly using liquid 
chromatography with electrospray ionization and mass spectrometry as well as nuclear 
magnetic resonance (NMR) analysis. Gas chromatography coupled with mass spectrometry was 
also used to identify degradation products (Winkler, Lawrence et al. 2001; Murdoch and Hay 
2005; Aranami and Readman 2007; Mac Leod, Faria et al. 2008; Matamoros, Caselles-Osorio et 
al. 2008; Takahashi, Kawashima et al. 2008; Schindler, Forster et al. 2009). Whenever more than 
one pathway was found for a certain compound, only those representing biodegradation caused 
by microorganisms were used for comparison with predicted metabolic pathway from Catalogic 
models (as explained below). 
For some compounds, degradation pathways carried out by microbial systems or 
microorganisms were not available in the literature. Most of these chemicals are recalcitrant 
and comprise amitriptyline hydrochloride, atorvastatin, diazepam, dilantin, gemfibrozil, 
meprobamate, primidone and risperidone. In this case, the degradation pathway available, most 
of the time from human systems, was used in comparison against the Catalogic predicted 
pathways. The systems or microorganisms used to degrade a certain parent compound and 
generate corresponding degradation trees (Appendix D) are described in Table 3.2.  
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Table 3.2 – Degradation pathways of target compounds from various literature sources 
Compound Reference Degradation by system/specie 
Acetaminophen UM-BBD Penicillium species 
Amitriptyline 
hydrochloride 
(Kasprzyk-Hordern, Dinsdale et 
al. 2007) 
Human metabolites 
Androstenedione 
UM-BBD 
Pseudomonas testosterone and Comamonas 
testosteroni 
Androsterone (Fahrbach, Krauss et al. 2010) Steroidobacter denitrificans 
Atenolol (Radjenovic, Perez et al. 2008) Aerobic degradation with activated sludge 
(Marco-Urrea, Radjenovic et al. 
2010) 
Oxidation in a biological Fenton-like system 
catalyzed by ligninolytic enzymes of Trametes 
versicolor 
Atorvastatin (Aviram, Rosenblat et al. 1998; 
Vanderford and Snyder 2006) 
Hydroxylated metabolites in human plasma 
Bisphenol A UM-BBD Gram-negative aerobic bacterium strain MV1 
Caffeine 
UM-BBD 
Psuedomonas putida and Serratia marcescens 
Rhodococcus and Klebsiella spp 
Carbamazepine (Bernus, Dickinson et al. 1996) Human plasma and urine 
(Mandrioli, Albani et al. 2001) Human plasma 
(Breton, Cociglio et al. 2005) Hepatic metabolism 
(Hata, Shintate et al. 2010) 
Treatment with laccase from white rot fungus 
Trametes versicolor 
(Marco-Urrea, Radjenovic et al. 
2010) 
Oxidation in a biological Fenton-like system 
catalyzed by ligninolytic enzymes of Trametes 
versicolor 
DEET UM-BBD Pseudomonas putida 
Diazepam 
 
(St-Pierre and Pang 1987; Kinani, 
Bouchonnet et al. 2007) 
Metabolites in blood perfusion medium and 
bile from rat liver 
(Acikgöz, Karim et al. 2009) Urine and human hepatocytes 
Diclofenac 
(Gröning, Held et al. 2007) 
Aerobic degradation with indigenous 
microflora of river sediments 
(Marco-Urrea, Pérez-Trujillo et al. 
2010) 
White-rot fungus Trametes versicolor 
Dilantin  Main metabolic pathway on human 
(Yasumori, Chen et al. 1999) Microsomal oxidation 
Estradiol (17β) (Lee and Liu 2002) Sewage bacteria 
Estriol 
(Ke, Zhuang et al. 2007) 
Isolated bacteria from artificial sandy aquifer 
belonging to the genus Agromyces 
Estrone 
(Haiyan and Shulan 2007) 
Sphingobacterium sp. strain JCR5 
 
(Combalbert and Hernandez-
Raquet 2010) 
Bacteria under aerobic, anoxic or anaerobic 
conditions, and algae 
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Ethinylestradiol 
(17α) 
(Haiyan and Shulan 2007) Sphingobacterium sp. strain JCR5 
(Cajthaml, Kresinov et al. 2009) Caenorhabditis elegans 
Gemfibrozil (Aviram, Rosenblat et al. 1998) Hydroxylated metabolites in human plasma 
(Hermening, Grafe et al. 2000) 
Plasma and urine of humans and in tissue 
homogenates of rats 
Ibuprofen (Mills, Adams et al. 1973) Rat, baboon and human plasma 
(Winkler, Lawrence et al. 2001) River biofilm systems 
(Zwiener, Seeger et al. 2002) Biofilm reactors and batch activated sludge 
(Murdoch and Hay 2005) Sphingomonas sp. strain Ibu-2 
(Matamoros, Caselles-Osorio et 
al. 2008) 
Horizontal subsurface flow constructed 
wetlands 
Meprobamate (Ludwig, Douglas et al. 1960) Urine of animals and humans; 
(Calisto and Esteves 2009) Human metabolites excreted in urine 
Naproxen (Zhong, Sun et al. 2003) Cunninghamella species 
(Marco-Urrea, Pérez-Trujillo et al. 
2010) 
White-rot fungus Trametes versicolor 
Phenylphenol 
UM-BBD 
Pseudomonas azelaica HBP1 and Rhodococcus 
sp. 
Primidone (Ferranti, Chabenat et al. 1998) Rat urine 
(Mac Leod, Faria et al. 2008) Human plasma 
Risperidone (Fang, Bourin et al. 1999) Human cytochromes 
Sulfamethoxazole (Trovo, Nogueira et al. 2009) Solar photo-Fenton 
(Gauthier, Yargeau et al. 2010) Rhodococcus rhodochrous 
(Wang, Li et al. 2010) 
Photoelectro-Fenton treatment using 
activated carbon fiber cathode and under UV 
irradiation 
TCEP 
(Takahashi, Kawashima et al. 
2008) 
Enrichment culture with dominant bacteria 
related to Acidovorax spp. and Sphingomonas 
spp. 
(Schindler, Forster et al. 2009) Human urine 
Testosterone 
UM-BBD 
Nocardia restrictus and Comamonas 
testosteroni 
Triclosan 
(Aranami and Readman 2007) 
Photodegradation 
 
(Kim, Kumarasamy et al. 2010) Sphingomonas sp. 
Trimethoprim (Eichhorn, Ferguson et al. 2005) Nitrifying activated sludge bacteria 
UM-BBD: access is available at http://umbbd.msi.umn.edu/index.html. 
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3.3 Description of Software Tools to Predict Biotransformation 
This study makes use of some prediction tools from the software Catalogic version 5.11.1 
acquired from the company OASIS, Bulgaria. This software predicts environmental fate of 
chemicals based on models able to simulate molecular transformations and generate metabolic 
pathways. The output relies on the logic of enzymatic reactions, where the substructure of the 
product of one reaction becomes the target for the next transformation in the hierarchy.  
The prediction of metabolic pathways for chemicals is done by a platform called MetaPath, 
which processes biodegradation metabolism databases for more than 550 chemicals. This 
feature systematically compiles experimental data on observed metabolites and 
biotransformation rates. Reactions include one set of 188 spontaneous transformations of 
highly reactive groups and a second set of 463 metabolic transformations such as oxidation, 
hydrolysis, carboxylation, dehalogenation, etc. For each transformation, the program also 
assigns a probability of occurrence, which is estimated using biodegradability tests data such as 
biochemical oxygen demand (Cajthaml, Kresinov et al.), CO2 production, ultimate half-lives, and 
quantities of metabolites. 
Possible metabolites and transformations of targeted chemicals can be identified for different 
environmental conditions. For instance, the four different models available: 28 days MITI (OECD 
301C), Abiotic 28 days MITI (OECD 301C), BOD kinetic (OECD 301F), and Soil BioPath. 
All the models are based on quantitative structure activity relationships (QSARs) and consider 
functional groups undergoing transformations as descriptors for the model. Soil BioPath is not 
discussed here because it goes beyond the scope of this work, which evaluates 
biotransformation of chemicals on aqueous systems (activated sludge treatment of 
wastewater). 
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28 days MITI (OECD 301C) and Abiotic 28 days MITI (OECD 301C) models simulates multi-
pathway biodegradation and abiotic degradation, respectively, and predict quantities of 
transformation products within the MITI I (OECD 301C) test conditions. BOD kinetic (OECD 301F) 
model also simulates multi-pathway biodegradation and predicts biodegradation and quantities 
of metabolites for a period of 10 days within the OECD 301F test conditions. 
Details on test conditions can be found elsewhere (OECD 1992). Briefly, 28 days MITI and BOD 
kinetic methods measure the oxygen uptake by a mixed community of microorganisms, during 
growth on a solution containing only essential minerals and the chemical to be tested. The 
microbes are not previously acclimated to any substance and are commonly obtained from 
diverse sludge sources. Incubation is performed during 10 or 28 days, according to each method, 
in a darkened respirometer around 25C. Biodegradation of the tested compound is expressed 
as the percentage of the theoretical oxygen demand (ThOD) uptake, corrected for blank uptake 
(Equation 3.2). 
 
                         
                         
                         
      
 
Catalogic uses the term percentage BOD to represent percentage removal, or percent 
biodegradation, which is calculated for models 28 days MITI and BOD Kinetic according to 
Equation 3.3 using probabilities of these transformations (Sakuratani, Yamada et al. 2005). 
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where kTOD is the theoretical oxygen demand, and Pi is the probability of initiation of the i-th 
transformation. Percentage BOD value could not be associated with the removal of the parent 
compound and was not evaluated in this study, once it accounts for the whole metabolic 
pathway, including degradation probabilities of metabolites. Once the program does not 
provide %BOD values for each of the terms in the equation, the resolution is not enough to 
determine the quota of the %BOD removal belonging to the first step degradation of the parent 
compound. It is important to note that the percent removal experimentally measured only 
represents the disappearance of the parent compound (“biotransformation”), and not its 
complete oxidation into CO2 and water (“biodegradation”). 
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IV. RESULTS AND DISCUSSION 
This chapter reports and discusses differences in the removal behavior of selected trace organic 
chemicals during conventional biological wastewater treatment and links these differences to 
structural differences of the selected TOrC. As mentioned before, the percent removal 
determined for TOrC in both treatment systems is reported as total removal and does not 
account for biotransformation alone because the amount of chemicals sorbed into the sludge 
was not measured. Therefore, percent removal is likely due to a combination of 
biotransformation and sorption. 
 
4.1 Biotransformation Rate Constants kbio and Percent Removal 
Biotransformation is represented by the rate constant kbio, which considers only the 
disappearance of the parent compound from the system, and not its complete oxidation to CO2 
and H2O. Bio-transformation rate constants, kbio, for selected trace organic chemicals were 
determined under aerobic conditions with sludge taken from the secondary treatment of two 
wastewater treatment facilities, Denver Metro and Mines Park (Table 4.1). Please note that kbio 
values exhibiting the sign “<” fell below the experimental resolution of the experimental 
method. The kbio values listed in Table 4.1 are considered the most determining parameter for 
the fate prediction of TOrC during wastewater treatment (Dickenson, Drewes et al. 2010). 
Unfortunately, these parameters are frequently inaccurate. This uncertainty is likely due to 
factors that affect biodegradation, such as differences in influent water quality characteristics, 
reactor design, flow scheme of the treatment train, other operational parameters of the facility, 
and the operational method employed to determine these constants (Smook, Zho et al. 2008). 
Temperature, availability of nutrients, initial concentration of chemicals, diversity of 
microorganism, and degree of acclimation may also affect biodegradation to a great extent 
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(Dickenson, Drewes et al. 2010). Beside these multiple factors potentially affecting rate 
constants, pseudo-first order transformation coefficients determined in laboratory-scale batch 
experiments were found to successfully predict removal of pharmaceuticals (β-blockers and 
psycho-active drugs) in the activated sludge process of a full-scale treatment plant (Wick, Fink et 
al. 2009).  
Solid retention time (SRT) is a key operational parameter in wastewater treatment dictating the 
growth rate of microorganisms and is thus another important parameter affecting 
biotransformation and the final concentration of contaminants in the effluent. Findings from 
previous studies (Clara, Kreuzinger et al. 2005) confirm the influence of SRT on removal of many 
TOrCs during wastewater treatment and suggest that for each chemical a critical SRT can be 
determined. Treatment plants operating above a critical SRT are expected to be able to degrade 
these compounds to a certain extent. For rate constants listed in Table 4.1, it is interesting to 
note that rate constants for the same compound differ between the two sludge types. This was 
expected since the laboratory experiments were carried out with sludge from a nitrifying and 
nitrifying/partially denitrifying treatment process employing different SRTs (5 days for Denver 
Metro and 11 days for Mines Park). Longer SRT, especially those where 
nitrification/denitrification is achieved, can result in more diverse microbial communities that 
are capable of degrading TOrC more efficiently as compared to communities representative of 
shorter SRTs. For many well biodegradable compounds targeted in this study, a better 
performance expressed by a larger rate constant was not observed when comparing sludge 
samples that represented 5 and 11 days of SRT. For moderately biodegradable compounds, such 
as atenolol, atorvastatin, diclofenac, gemfibrozil, ibuprofen, and triclosan, longer SRTs resulted 
in higher biotransformation rate constants. 
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Biological transformation constants also vary greatly between the set of TOrCs evaluated. Since 
these chemicals represent a wide range of different functional and structural moieties, the 
different degradation behavior might be structural related. The importance of the chemical 
structure is further discussed in subsection 4.5.  
Another study attempted to predict removal of chemicals in activated sludge systems using 
pseudo-first-order rate constants acknowledging the variability of performance for different 
sludge types and reactor conditions. This classification scheme considers the most persistent 
compounds to exhibit a kbio below 0.1 L/day.gSS; chemicals expressing kbio between 0.1 and 10 
L/day.gSS would be only partially removed, and removal higher than 90 percent would occur for 
kbio higher than 10 L/day.gSS (Joss, Zabczynski et al. 2006). Adjusting kbio unit to (day
-1) and 
multiplying the values above by MLSS concentration of 2 g/L for Denver Metro and 1.5 g/L for 
Mines Park, this generalization does not apply to kbio values from atenolol, DEET, ethinylestradiol 
(17α), risperidone, and triclosan. 
Sorption of the chemical onto sludge can be described by the solid-water distribution coefficient 
Kd (L/KgSS) presented in Table 4.1. This coefficient is defined as the ratio of chemical 
concentration on the solids to the corresponding concentration in the aqueous phase, at 
equilibrium conditions (Dickenson, Drewes et al. 2010). Kd represents a significant tool to predict 
whether the partition of compounds onto solids is relevant for their removal during activated 
sludge treatment, because it contemplates the two main sorption mechanisms (Ternes, 
Herrmann et al. 2004), absorption and adsorption, associated with the previously described 
physicochemical properties logKow and pKa, respectively. 
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Table 4.1 – Biological transformation constants, solid-water partition coefficients, percentage 
removal of chemicals from two wastewater treatment plants and from various literature 
sources (Appendix C) 
Compounds Denver Metro Sludge Mines Park Sludge Percent 
Removal 
Range from 
Literature 
kbio (h
-1
) 
Kd 
(L/KgSS)
a
 
Percent 
Removal 
kbio (h
-1
) 
Kd 
(L/KgSS)
a
 
Percent 
Removal 
Acetaminophen nd <30 nd 6.9777 <30 1 98.2 to 99.9 
Amitriptyline 
hydrochloride 
67.9019 4555 0.970 nd 2686 0.755 96 to 97.8 
Androstenedione 106.385 156 1 124.941 134 1 93 to 99.5 
Androsterone 142.450 579 1 122.189 419 1 99.3 to >99 
Atenolol 0.4547 <30 1 1.3332 35 1 0 to 84 
Atorvastatin 0.0231
b
 198 0.249 0.0597 93 0.804 51.3 
Bisphenol A 14.9781 431 0.899 0.5972 505 0.794 10.5 to 100 
Caffeine 21.8273 <30 1 5.5413 <30 1 44 to 100 
Carbamazepine <0.0192
b
 50 -0.159 <0.0192
b
 36 0.145 <0 to 76.4 
DEET 0.4914 42 1 0.2588 <30 0.921 0 to 91 
Diazepam 0.0012 241 0.300 <0.0192
b
 197 0.212 nd 
Diclofenac <0.0192
b
 <30 -0.769 0.0035 <30 0.135 0 to >81 
Dilantin 0.0118 81 0.358 <0.0192
b
 32 -0.110 5.4 to 44 
Estradiol (17β) 126.205 771 1 19.4086 533 1 39.5 to 98.4 
Estriol nd 63 nd 4.0804 54 1 67.1 to 99.8 
Estrone 14.6585 645 1 49.1855 607 1 <0 to 98.5 
Ethinylestradiol (17α) 0.2527 1550 1 0.2715 1103 1 37.5 to >98 
Gemfibrozil 0.0711 45 0.967 1.1040 30 1 <10 to >92.8 
Ibuprofen 0.0341 <30 0.430 1.4174 <30 0.953 43 to 99.8 
Meprobamate <0.0192
b
 <30 0.065 <0.0192
b
 <30 -0.028 14.5 
Naproxen 2.4530 <30 0.793 0.5519 <30 0.973 14.7 to 99.9 
Phenylphenol 67.2407 347 1 0.3134 259 1 80 
Primidone <0.0192
b
 <30 -0.023 <0.0192
b
 <30 0.091 0 to 64.6 
Risperidone 137.643 861 0.882 nd 669 0.471 95.8 
Sulfamethoxazole 0.0205 <30 0.357 0.0178 <30 0.301 <0 to 76 
TCEP <0.0192
b
 65 -0.183 <0.0192
b
 <30 -0.335 0 to 50 
Testosterone 178.012 157 1 117.601 136 1 91.6 to 100 
Triclosan 0.0994 na 1 81.2848 na 1 30 to 96 
Trimethoprim <0.0192
b
 119 0.073 0.0062 193 0.354 <0 to 91.9 
a Kd values from (Stevens-Garmon, Drewes et al. 2011) 
b Kb values from (Dickenson, Drewes et al. 2010)  
nd: not determined   na: not available 
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According to Joss, Keller et al. (2005) a sorption coefficient lower than 300 L/KgSS usually 
indicates that sorption of the chemical onto secondary sludge is not relevant and transformation 
is the main mechanism responsible for decrease of chemical concentrations in the effluent. 
Other two studies had identified that sorption does not contribute significantly to total percent 
removal of a substance in WWTPs if the Kd value is below 100 L/KgSS (Joss, Zabczynski et al. 
2006) or even below 500 L/KgSS (Ternes, Herrmann et al. 2004). 
The range of percent removal for the targeted TOrC as reported in the literature is also compiled 
in Table 4.1 for comparison (individual references are summarized in Appendix C). The very 
broad ranges of removal could be explained by the variable operational conditions reported in 
different publications. For instance, when referring to percent removal, the hydraulic retention 
time of the system may also play a role for biotransformation. It is clear that giving more time 
for the compounds to interact with the microorganisms in the mixed liquor allows reactions to 
occur that are characterized by low rate transformations. However, opposing conclusions have 
been reached regarding HRT influence on removal. Maurer et al. (2007) observed that 
elimination of β-blockers during activated sludge treatment with typical MLSS of 4 gCOD/L 
increased with an increasing hydraulic retention time (HRT). Removal of ibuprofen also appears 
to increase for a treatment plant operating at twice the HRT (Smook, Zho et al. 2008). 
Alternatively, Joss et al. (2005) reported that HRT has only a minor influence on the removal of 
pharmaceuticals in a full-scale nutrient-removing treatment facility.  
Literature percent removal values are lower than zero when the concentration of the chemical is 
greater in the effluent than in the influent. The reason for that is unclear for some compounds, 
but there are several proposed explanations, such as sampling inaccuracy, desorption of the 
compound from particles present in the influent, or disregard of conjugate compounds in the 
influent being retransformed into the parent chemical during the treatment process (Joss, Keller 
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et al. 2005). In addition, highly loaded process streams, such as supernatant return flows from 
solids processing, can contribute significant mass loads that can exceed concentrations in the 
influent (Drewes, Hemming et al. 2005).  
A combination of several factors may result in high variability in the percent removal of estrone 
across the different studies. Cleavage of conjugated steroid estrogens can double the amount of 
estrone and 17β-estradiol in the first stages of activated sludge treatment (Joss, Andersen et al. 
2004). Rapid degradation of 17β-estradiol to estrone has been reported (Ternes, Stumpf et al. 
1999; Lee and Liu 2002), and also increases estrone concentrations during the first hours of 
treatment. Estrogen degradation is mainly observed during denitrification (Joss, Andersen et al. 
2004); as the operational conditions vary between treatment plants, the percent removal also 
diverges. If time and/or conditions needed for further degradation of estrone are not 
satisfactory, an apparent accumulation of this hormone in the final effluent can be observed 
(Servos, Bennie et al. 2005). 
Other plausible reasons for compounds exhibiting negative removal values are discussed in 
detail in the next section, in which kbio constants determined in this study are used to predict 
removal of TOrCs from wastewater of other treatment facilities. 
 
4.2 Correlation of Observed versus Predicted Removal 
Biotransformation constants obtained in this study were used to assess removal of compounds 
by biotransformation, considering data and operational conditions of WWTPs gathered from the 
literature. The aim of this exercise was to determine if a kbio obtained from controlled laboratory 
experiments using activated sludge from a treatment facility can be used to predict the removal 
of a chemical from another treatment plant with similar operational conditions. 
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Removal data were compiled from the literature on removal of TOrCs during wastewater 
treatment and are summarized in Appendix C. Details about the treatment facilities, operational 
conditions, as well as initial concentration and percentage removal of the chemicals are also 
provided. The data gathered is not intended to be an exhaustive list of all studies available on 
removal of TOrCs from WWTPs. The information compiled was actually selected from the peer-
reviewed literature based on available information required for comparison between the 
removal performances of different facilities. For certain compounds, very few studies were 
available for activated sludge systems, so membrane bioreactors were also considered. 
Preference was given for studies on activated sludge systems containing information on HRT 
and reporting SRTs below 20 days, since this was one of the criteria to selected data for removal 
predictions using kbio values, which were determined for SRTs of 5 days and 11 days, 
respectively. Equation 4.1 was used to compute the predicted final concentration of the TOrC,  
 
           
       
 
and percent removal is calculated from Equation 4.2, 
 
                
         
    
     
 
where Ceff is the predicted concentration in the final effluent, Cinf is the concentration measured 
in the influent wastewater for each referenced study, and t is the operating HRT of the system in 
the study. Note that Equation 4.1 does not include the term XSS, or MLSS concentration. This 
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parameter was usually not available in the referenced studies, but when present, it does not 
vary much among the activated sludge systems (generally between a range from 1 to 4 g/L). 
For SRTs equal or below 7 days, biotransformation rate constant kbio from Denver Metro (SRT of 
5 days) was replaced in Equation 4.1, while for SRTs between 8 and 20 days, kbio from Mines 
Park (SRT of 11 days) was applied. Literature data missing HRT values or reported SRT values 
above 20 days were rejected in this calculation.  
 
4.2.1 Quality Assurance of Data Set Considered for Correlation 
Androstenedione and meprobamate singular data points were disregarded due to inadequacy of 
SRT (information missing and value above 20 days, respectively). Because kbio predicts only 
biotransformation, compounds that are likely to sorb onto sludge were not considered in this 
assessment. Therefore, another threshold to exclude TOrCs removal data was Kd values higher 
than 200 L/KgSS. Chemicals rejected were amitriptyline hydrochloride, androsterone, bisphenol 
A, diazepam, estradiol (17β), estrone, ethinylestradiol (17α), phenylphenol, and risperidone. 
Although Kd values were not available for triclosan, McAvoy et al. (2002) identified that this 
antimicrobial is removed from influent mainly due to sorption. Hence only two data points were 
kept from this study, which distinguishes between percent removal of triclosan by 
biotransformation and by sorption (McAvoy, Schatowitz et al. 2002). 
Sulfamethoxazole was also excluded because most studies did not assess the presence of N4-
acetylsulfamethoxazole, the main human metabolite of sulfamethoxazole present in high 
amounts in the primary effluent (Göbel, McArdell et al. 2004). During the treatment process, 
this metabolite may be retransformed into the parent compound (Göbel, Thomsen et al. 2005), 
and if the metabolite concentration is neglected, removal of the antibiotic is underestimated 
(Göbel, McArdell et al. 2004; Joss, Keller et al. 2005). Due to human metabolism, 
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sulfamethoxazole itself accounted for only 14 to 44 percent of the total influent load (Göbel, 
Thomsen et al. 2005), and its degradation happens concomitant with its appearance from N4-
acetylsulfamethoxazole transformation. This might also explain the high variability of removal 
data for this compound (Göbel, McArdell et al. 2007).  
From the remaining 16 compounds, some data points were also eliminated for different reasons 
often related to lack of adequate information of each individual study. For instance, negative 
removals determined for carbamazepine and trimethoprim have no significance to evaluate 
biotransformation, and these data points were not taken into account.  
The “appearance” of carbamazepine in the treated effluent can be explained by the cleavage of 
conjugates (Nakada, Tanishima et al. 2006). For all referenced studies on carbamazepine 
removal, concentration of conjugates in the influent were neither measured nor accounted for 
in the total concentration of the parent compound. It also known that conjugates show lower 
biotransformation rates compared to the free form of the chemical, and consequently percent 
removal is lower for TOrCs able to form conjugates (D'Ascenzo, Di Corcia et al. 2003; Wick, Fink 
et al. 2009). 
Negative removals of trimethoprim are justified by exclusion of particulate matter greater than 
0.45 µm in the analysis of the influent. Once these particles carry adsorbed TOrCs that are 
desorbed during the treatment process, the total content entering the system would be 
underestimated (Lindberg, Wennberg et al. 2005). Deconjugation of metabolites leading to 
formation of trimethoprim is also a proposed explanation (Gulkowska, Leung et al. 2008).  
Roberts and Thomas (2006) reported that concentrations of trimethoprim in the final effluent 
are higher than in the influent likely because the MS/MS detector signal was suppressed when 
measurements were taken from solutions rich in organic matter. Consequently, data from this 
study were rejected. Finally, all data sets for trimethoprim were disregarded, because 
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Radjenovic et al. (2009) and Göbel et al. (2004, 2005, and 2007) determined Kd values higher 
than 200 L/Kg, i.e. sorption is relevant for removal, despite Kd values reported in Table 4.1  being 
below the threshold. 
A study reporting high removal of diclofenac (Metcalfe, Koenig et al. 2003) was excluded due to 
inaccuracy of the detection method applied: the analgesic was not identified in the effluents 
because the sensitivity of GC-MS analyses was low. Another survey published in the same 
journal by the same author (Metcalfe, Miao et al. 2003) recognized that diclofenac can be found 
in the effluent if an analytical technique with greater sensitivity is applied (LC-ESI-MS-MS); that 
would certainly lead to lower percent removal. 
Caffeine data points from the reference Santos et al. (2009) were rejected due to high relative 
standard deviations (from 82 to 119%) associated with the percent removals. Besides, the study 
presents mean percent removal values of measurements made across one year time in both 
primary and secondary treatment, and does not show individual points associated with the 
variable operational conditions of the treatment plant. 
 
4.2.2 Correlation between Observed and Predicted Removal of TOrC 
After this preliminary selection of relevant literature studies, predicted versus observed removal 
data were plotted (Figure 4.1) considering 105 data points for 16 TOrCs (acetaminophen, 
atenolol, atorvastatin, caffeine, carbamazepine, DEET, diclofenac, dilantin, estriol, gemfibrozil, 
ibuprofen, naproxen, primidone, TCEP, testosterone, and triclosan). Color code was used for 
compounds that were considered with more than 2 data points. 
  
 
 
 
Figure 4.1 – Plot of predicted removal of TOrCs from WWTPs using kbio constants determined in this study versus referenced observed 
removal for respective WWTPs. Compounds with two or less data points are shown in black and include acetaminophen, atorvastatin, 
dilantin, primidone and triclosan. 
R² = 0.4476
0
10
20
30
40
50
60
70
80
90
100
0 10 20 30 40 50 60 70 80 90 100
O
b
se
rv
e
d
 R
e
m
o
va
l (
%
)
Predicted Removal (%)
All
Atenolol
Caffeine
Carbamazepine
DEET
Diclofenac
Estriol
Gemfibrozil
Ibuprofen
Naproxen
TCEP
Testosterone
Linear (All)
 
 
While removal data for the same TOrC varies considerably within measurements of the same 
treatment plant, generally observed removal percentages fell within specific clusters for each 
compound. For better accuracy of prediction, ranges of observed removal were assessed. This 
analysis considered only TOrCs having four or more data points, and both observed and 
predicted removals are listed in Table 4.2. 
Table 4.2 – Comparison between observed and predicted ranges of removal in percentage 
Compound Observed Removal Predicted Removal Prediction Efficiency 
Atenolol Between 40 and 85 >90 - 
Caffeine >85 >90 ++ 
Carbamazepine <50 <45 ++ 
DEET Between 20 and 85 >65 - 
Diclofenac <35 <10 ++ 
Estriol >90 >95 ++ 
Ibuprofen Between 40 and 100 Between 7 and 100 - 
Naproxen Between 40 and 100 >95 - 
Testosterone >90 100 ++ 
 
TOrCs exhibiting relatively good prediction of removal comprise caffeine, estriol, and 
testosterone, all known to be very biodegradable compounds. Predicted removals for atenolol 
and naproxen were both overestimated, while ibuprofen exhibited a very broad and 
inconsistent range of predicted removal (see also Figure 4.1).  For recalcitrant TOrCs (i.e., 
carbamazepine, diclofenac), the ranges agreed better, but data points should be evaluated 
individually, as pairs of data might diverge (e.g., 43.8 and 0 for carbamazepine). The number of 
compounds evaluated in the range of comparison was not enough to associate prediction 
efficiency with chemical structures. 
These findings suggest that predictions relying on kbio values determined under controlled 
conditions for two different SRTs although representative of many conventional activated sludge 
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plants are limited to properly describe the fate of TOrCs in treatment plants with similar SRTs. 
The low coefficient of determination (R2 = 0.4476) indicates that additional factors should be 
taken into account in order to generate a more accurate prediction. It is suggested that a more 
careful investigation and selection of literature data should be performed. Especially focus could 
be given to: 
a) Removal data considering only secondary treatment, so that losses in the primary treatment 
are not contributing to biotransformation; 
b) The operational conditions of the WWTPs need to be within a narrow window of conditions 
similar to the range of conditions where kbio were determined, considering not only SRT, but 
also influent and effluent quality parameters, MLSS concentration, nitrifying or 
nitrifying/partially denitrifying activated sludge, and degree of adaptation to presence of 
TOrC; 
c) HRTs values described in the study, making sure that they are related to the activated sludge 
system and not the whole treatment plant; 
d) Use of proper analytical methods that compensate losses of the chemical due to matrix 
effects, such as isotope-dilution LC-MS/MS method. 
 
4.3 Comparison between Metabolic Pathways 
This section discusses the differences between predicted degradation pathways from Catalogic 
software for three different models: Abiotic 28 days MITI (OECD 301C), 28 days MITI (OECD 
301C), and BOD kinetic (OECD 301F). The output of one biodegradation model for targeted 
TOrCs is then compared with metabolic pathways for these TOrCs compiled from the literature. 
Because the ultimate aim of this section is to link information on biodegradation pathways with 
collected biotransformation data (kbio and percent removal), only the first biodegradation 
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reactions responsible for disappearance of the parent compound were considered for 
comparison purposes. A relation between experimental determined percent removal and 
software predicted probability of degradation of the parent compound is also investigated. 
 
4.3.1 Abiotic Degradation versus Biodegradation Pathways 
For each targeted TOrC input in Catalogic, three different degradation pathways can be 
generated using the three models available. In order to assess the differences between the 
three simulations, the more simple abiotic degradation pathway (model “Abiotic 28 days MITI”) 
was contrasted with the two more complex aerobic biodegradations trees (“28 days MITI (OECD 
301C)” and “BOD kinetic (OECD 301F)”). 
There was no record of abiotic degradation for 17 of the 29 TOrCs and Table 4.3 summarizes the 
results of a comparison between the models for only those 12 compounds having abiotic 
transformation pathways available.  
Some of the abiotic transformations also include ionization, but this type of conversion does not 
contribute to removal, since the compound can be easily re-established to its original neutral 
form due to changes of physicochemical conditions during the treatment process. 
The first reaction and associated probability are described for the abiotic pathway in Table 4.3. If 
the same reaction was identified in the other two pathways, a “Yes” is reported in columns four 
and five, as well as probability values referent to the models. To illustrate the outcome of the 
comparisons, acetaminophen was chosen as an example and the output pathways from the 
three models are presented in Figure 4.2. 
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Table 4.3 – Comparison of degradation pathways for selected TOrCs using Catalogic 
Compound Abiotic Pathway Biodegradation Pathways 
First Reaction Probability Present in OECD 301C? Present in OECD 301F? 
Acetaminophen Amine 
hydrolysis 
0.03 Yes, first most probable 
reaction P=0.677 
Yes, first only reaction 
P=0.1 
Amitriptyline Ammonium 
decomposition 
0.999 Yes, first only reaction 
P=1 
Yes, first only reaction 
P=1 
Atenolol Amide 
hydrolysis 
0.999 Yes, nitrile and amide 
hydrolysis, highest 
probability, subsequent 
oxidative deamination 
Yes, most probable 
pathway 0.917, with 
subsequent 
hydroxylation 
Atorvastatin Amide 
hydrolysis 
0.03 Yes, but beta oxidation 
occurs twice before the 
first amide hydrolysis 
Yes (P=0.091), but beta 
oxidation is the most 
probable reaction 
P=0.908 
Caffeine Amide 
hydrolysis 
0.617 Yes, but it’s just one of 
the many possible 
degradation pathways 
P=0.135 
Yes, and it’s the only 
reaction being 
predicted, similar 
P=0.65 
DEET Amide 
hydrolysis 
0.617 Yes, but it’s just one of 
the many possible 
degradation pathways 
P=0.31 
Yes, the first 
degradation predicted, 
P=0.65 
Diazepam Amide 
hydrolysis 
0.001 Yes, and occurring with 
higher P of 0.381 
Yes, the only first 
reaction occurring in 
the pathways with a 
P>0 (P =0.65) 
Dilantin Amide 
hydrolysis  
0.029 Yes, and all three of 
them exhibiting the 
same highest P=0.287 
Yes, first and second 
alone (belonging to the 
same branch) reaction 
with P=0.999 
Meprobamate Ester hydrolysis 0.036 Yes, but called 
carbamate hydrolysis, 
same products, P=0.086 
No transformation 
predicted 
Primidone Amide 
hydrolysis 
0.03 Yes, with the highest 
P=0.352 
Yes, first only reaction 
P=0.5  
Risperidone Amine cleavage 0.039 No, other reactions 
taking place in different 
fragments 
No, hydrolysis happens 
in a different fragment 
TCEP Dehalogenation 
and phosphate 
hydrolysis  
0.223 and 
0.105 
Yes, first and only 
reaction is a phosphate 
hydrolysis (P=0.01) and 
subsequent reactions 
have P=0 
Yes, first and only 
reaction is an oxidative 
dehalogenation 
P=0.331 
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Figure 4.2 – Predicted degradation pathways for acetaminophen using three different models 
from Catalogic. 
 
 
Abiotic 
OECD 
301C 
28 days MITI 
OECD 301C 
BOD kinetic 
OECD 301F 
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The first abiotic reaction for this analgesic is also present in the other two biodegradation 
pathways; these reactions produce the same metabolites. In this example, predicted 
degradation paths using the model “28 days MITI” contain all the transformations of the other 
biotic model. This was also observed for 28 other TOrCs (except TCEP), and is likely due to the 
time duration of the biodegradability tests considered for the prediction in this model (28 days 
for OECD 301C versus 10 days for OECD 301F) where abiotic reactions can easily occur. 
Therefore, only biodegradation pathways generated by “28 days MITI” model were chosen for 
comparison of pathways between the software and peer-reviewed pathways (section 4.3.2).  
Considering acetaminophen pathways, the probability of occurrence of the same (first abiotic) 
reaction varies between the models. From results reported in Table 4.3, it is possible to 
conclude that for most TOrCs, the abiotic reaction is present in the biodegradation pathways 
and is usually associated with a higher probability. One possible explanation is that the fragment 
transformed at abiotic conditions is more amendable to biodegradation, i.e. if probability for the 
same reaction is higher at biodegradation pathways than at abiotic ones, then the 
microorganisms are probably catalyzing the attack of this fragment. If a chemical has many 
other possible biodegradation pathways branching from the parent compound, the probability 
of the abiotic reaction to occur may be reduced in the biotic models, because the sum of all 
degradation probabilities for a compound must be less than or equal to 1. In this case (e.g., “28 
days MITI” for caffeine and DEET), the reduction in probability does not mean that the extent 
with which the reaction is occurring has been reduced. 
For an unknown reason, the comparison between TCEP prediction pathways differs from the 
other compounds. Firstly, the presence of three equal fragments in the molecule makes the 
combination of reactions for the abiotic degradation pathway very broad. On the degradation 
tree, the same reaction is predicted over and over again, just alternating the branch. A similar 
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behavior is noticed on all three pathways predicted for dilantin: the presence of two amide 
groups on the structure of dilantin leads to a bigger variety of metabolites obtained with the 
same transformation, i.e. amide hydrolysis. 
Secondly, TCEP is the only compound in which the degradation predicted by the “28 days MITI” 
model does not include the reactions of the “BOD kinetic” model. Finally, the probability of 
phosphate hydrolysis to occur is lower under biotic conditions (P = 0.01 for 28 days MITI model 
versus P = 0.105 for abiotic model). A reason for that could be that phosphate esters hydrolysis 
is very pH-dependent and usually does not take place in acidic or neutral solutions (Agency for 
Toxic Substances and Disease Registry (ATSDR) 2009). The microbial growth might contribute to 
pH decay and hinder the abiotic degradation of TCEP by phosphate hydrolysis. Second and third 
ester substituents are much harder to be hydrolyzed if the first ester branch has been removed 
(Agency for Toxic Substances and Disease Registry (ATSDR) 2009), and this explains subsequent 
probabilities equals to zero for the same reaction. 
Understanding abiotic pathways and their first probabilities is very relevant for the comparison 
between predicted and observed transformations, which is discussed in the next section. 
Determination of kbio constants only takes into account disappearance of the parent compound 
due to biotransformation, because removal due to other mechanisms is eliminated using an 
abiotic control (blank). From the abiotic probability data presented in this section, it was 
observed that TOrCs with negligible sorption (Kd < 50 L/Kg) and high probability values for first 
abiotic reaction show relatively low kbio values although removal of these compounds is still very 
high. For instance, atenolol and DEET exhibited low biotransformation rates (0.4547 and 1.3332 
for atenolol, 0.2588 and 0.4914 for DEET), and yet the observed high removal percentages 
(100% for atenolol, 92 and 100% for DEET) are clearly not due to sorption. Caffeine has also 
relatively low kbio values (21.8273 and 5.5413) compared to other well biodegradable 
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compounds (kbio values from all easily degraded androgens are higher than 100) and exhibited 
100 percent removal (not due to sorption considering previously determined Kd values of less 
than 30).  
Thus, it is concluded that abiotic transformations (0.617 < P < 0.999) play an important role in 
removal of these compounds during wastewater treatment (probabilities of abiotic reactions to 
occur is higher than 60%). For this reason, and also because probabilities provided by Catalogic 
models usually consider likelihood of a fragment to be attacked, regardless of whether the 
reaction modifying the fragment is  occurring in abiotic or biotic conditions (TCEP is again an 
exception), probabilities of transformations were compared with percent removal data instead 
of kbio values in the next section (Figure 4.4). 
 
4.3.2 Biodegradation Pathways versus Metabolic Pathways from Literature 
The results of a comparison between biodegradation pathways predicted by “28 days MITI” 
model and selected metabolic pathways from literature (refer to section 3.2 and Appendix D) 
are summarized in Table 4.4. The probability of a compound to be biotransformed is extracted 
from the model and listed in column two in Table 4.4. However, a detail comparison between 
predicted and published degradation pathways revealed that some predicted reactions were 
never confirmed through studies reported in the literature. Therefore, a correction of the 
accumulated probability values was performed, taking into account only those pathways 
associated with reactions confirmed by pathways reported in the peer-reviewed literature. 
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Table 4.4 – Corrected predicted probability values from “28 days MITI (OECD 301C)” model 
based on evaluation of predicted and peer-reviewed pathways 
Compound 
Probability 
28 days 
MITI 
Correction for Literature 
Final P 
Values 
Acetaminophen 0.7113 0.677 0.677 
Amitriptyline 
hydrochloride 
1 
0.736 0.736 
Androstenedione 1 none 1 
Androsterone 1 none 1 
Atenolol 0.9547 none 0.9547 
Atorvastatin 1 metabolites  do not match literature - 
Bisphenol A 0.3027* correction was not possible - 
Caffeine 0.9966 none 0.9966 
Carbamazepine 0.6444 0.504 0.504 
DEET 0.863 none 0.863 
Diazepam 1 0.381 0.381 
Diclofenac 0.0358 none 0.0358 
Dilantin 0.9004 0.020 0.020 
Estradiol (17β) 1 none 1 
Estriol 1 none 1 
Estrone 1 none 1 
Ethynylestradiol (17α) 0.3874 metabolites  do not match literature - 
Gemfibrozil 0.3166 miss some metabolites from literature 0.3166 
Ibuprofen 0.1192 miss some metabolites from literature 0.1192 
Meprobamate 0.5285 0.089 0.089 
Naproxen 0.07032 metabolites matching have P = 0 and P > 0 are 
given for unrecognized ones; miss some literature 
metabolites 
- 
Phenylphenol 0.8758 none 0.8758 
Primidone 0.8085 0.352 0.352 
Risperidone 1 0.525 0.525 
Sulfamethoxazole 1 metabolites matching have P = 0 and P > 0 are 
given for unrecognized ones; miss some literature 
metabolites 
- 
TCEP 0.02891 none 0.02891 
Testosterone 1 none 1 
Triclosan 0* all metabolites matching have P = 0 - 
Trimethoprim 0.9961 0.332 miss some metabolites from literature 0.332 
*BOD values are set to zero in the software and are affecting probability. 
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Prediction of pathways by the biodegradation models embedded in Catalogic was correct for 
more than 40 percent of the selected TOrCs, i.e. no correction of the probability value was 
necessary because the predicted reactions match the ones reported in peer-reviewed literature. 
The degree of agreement with literature studies was moderate for 38 percent of chemicals from 
the data set, i.e. predicted degradation trees either presented more pathways and reactions 
than those reported in the literature, or did not comprise all the metabolites observed in 
metabolic pathways from the literature. For these compounds, the probability values were still 
adopted but a correction of the value was performed. For instance, probability value for 
acetaminophen was adjusted according Figure 4.3. 
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Figure 4.3 – Illustration of procedure for adjustments of probabilities taking acetaminophen as 
an example. A) Published degradation pathway from UM-BBD, and B) Predicted degradation 
pathway using model “28 day MITI”. Since aromatic ring oxidation is not present in the peer-
reviewed pathway, probability associated with this reaction is eliminated, thus corrected P 
value is equal to 0.677 only, instead of 0.712 (second column of Table 4.4). 
A 
B 
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Column four of Table 4.4 presents the corrected probabilities values for 23 of the 29 TOrCs that 
were used to contrast predicted transformation probability with observed removal data for the 
two treatment plants investigated in this study, Denver Metro and Mines Park. The results of 
this comparison are illustrated in Figure 4.4. 
 
 
Figure 4.4 – Plots of new probability values of degradation of TOrCs considering metabolic 
pathways analysis versus observed percent removal on Denver Metro and Mines Park 
treatment systems. 
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The high coefficients of determination (R2 = 0.82 and 0.9) indicate that transformation 
probabilities predicted by model “28 days MITI” from Catalogic (some corrected based on 
literature studies) correlated well with removal rates for the two different treatment plants. 
 
4.4 Fragment Analysis 
Qualitative data on biodegradability of compounds has been used in mathematical models to 
predict biodegradation from chemical structure (Boethling, Howard et al. 1994). Such models 
use structural fragments known to facilitate transformation as descriptors (Klopman, Tu et al. 
1997) in either linear or non-linear equations. BIOWIN models, for example, requires only the 
chemical structure to predict semi-quantitative estimates of biodegradability of a certain 
compound (Tunkel, Howard et al. 2000). The 42 fragments used as descriptors in the MITI 
Biodegradation Models (Biowin 5 and Biowin 6) were considered in this section, and Appendix E 
shows that nearly 62 percent of them are present in the selected 29 TOrCs. Observing peer-
reviewed degradation pathways (accessible in Appendix D) for the 29 compounds, the first 
fragments attacked during biotransformation were determined, comprising approximately 45 
percent of the 42 substructures. Indicator compounds selected to represent a broad range of 
potential biotransformation pathways should be comprised of the most commonly found 
organic fragments. BIOWIN models 5 and 6 use atoms of a substance only once to determine if a 
given fragment is part of the molecule or not (Tunkel, Howard et al. 2000). The 42 substructures 
for the set of TOrCs investigated in this study were extracted from the output of the model 
BIOWIN 6 and are illustrated in Figure 4.5 (the number of substructures identified is marked in 
patterned bars). In order to investigate the importance of certain fragments for 
biotransformation of the parent compound, the frequency of each fragment being attacked 
during the first reactions is also represented in Figure 4.5 (black bars). 
 
 
 
Figure 4.5 – Patterned bars represent counts of 26 structural fragments present in the chemical structures of the 29 target TOrCs. Of them, 20 
are attacked during the first biotransformation reaction of the compound according to degradation pathways from literature. The frequency 
(in percentage) of this event for a certain fragment is shown in black bars. 
 
 
The frequency with which a fragment is attacked during the first transformation differs between 
the fragments present in the 29 TOrCs. Although some fragments are not very abundant, such 
as amides, they are more frequently modified in the first reaction than very recurrent one such 
as aromatic hydrogen. Therefore, the presence of substructures frequently attacked, like 
amines, amides, and aliphatic alcohols in a molecule could encourage biodegradation. However, 
more TOrCs should be assessed to actually link certain attacked fragments to preferred 
degradation. Also, an evaluation coupled with probability of occurrence of a certain attack might 
be more relevant, because some reactions involved in the transformation of a certain fragment 
might be more or less likely to occur, depending on the compound. For instance, amide is always 
the first fragment being attacked based on pathway studies reported in the literature for the 29 
TOrCs, but compounds having amide fragments are not always more likely to be better 
degradable (low probability of occurrence).  
Since the analysis of the fragments alone does not provide much information on the likelihood 
of biodegradation of a certain compound, a more comprehensive discussion taking into account 
different data gathered in this study is presented in the next section. 
 
4.5 Identification of Indicator Compounds 
Data from sections 4.1 to 4.4 were used in order to develop an approach using attacked 
fragments to identify compounds that can represent the behavior of other compounds with 
similar chemical structure among the 29 TOrCs listed. Biodegradability of different classes of 
chemicals during activated sludge treatment was correlated with the presence of certain 
fragments in the chemical structure. Thus, certain compounds can be used to serve as indicators 
for the elimination of substances that have similar structures with the same fragments 
susceptible to be attacked during microbial degradation. Therefore, compounds from Figure 4.6 
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can be grouped into two different categories considering the experimentally determined degree 
of biodegradability, predictions from Catalogic models, and metabolic pathways published in 
peer-reviewed journals (Table 4.5). 
 
 
 
 
   Testosterone          Androsterone          Androstenediol              Estradiol             Phenylphenol 
 
 
 
 
     Primidone              Carbamazepine  Dilantin     Diazepam 
Figure 4.6 – Chemical structures of some of the selected TOrCs. 
The first group of very biodegradable compounds (removal >90%) is characterized not only by 
high removal percentages, but also the presence of an alcoholic functional group being oxidized 
during the first or second transformation, which also happens to be very likely to occur. All the 
structures of hormones in this group contain a steroid backbone and are very alike, but 
apparently the presence of the alcoholic group (and ketones) common in hormones and 
phenylphenol is the determining factor promoting biodegradation. This fragment is also present 
and attacked in other biodegradable TOrCs, such as ethinylestradiol, estriol, estrone, atenolol 
and gemfibrozil.  
The second group of more recalcitrant compounds exhibits removal percentages below 30 
percent. For these chemicals, amide hydrolysis is the first reaction happening, with low values of 
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probability associated with it. Amide and aromatic hydrogen are the attacked fragments listed, 
but to relate these with poor biotransformation, a more careful interpretation is required taking 
into account other listed TOrCs. 
Acetaminophen, DEET, and caffeine all have amide fragments being transformed during the first 
step of their degradation pathways. However, these three TOrCs are very well removed during 
activated sludge treatment. Aromatic hydrogen fragments are also present and attacked in 
moderately biodegradable compounds, such as amitriptyline hydrochloride, atorvastatin and 
gemfibrozil. This finding suggests that one fragment alone cannot characterize the entire 
chemical structure of a molecule and is not representative to directly estimate biodegradation. 
The fact that amide or aromatic hydrogen fragments can be easily attacked in some molecules 
and not in others emphasizes the need of considering reactions and probabilities together.  
Table 4.5 – Compilation of analyzed data from sections 4.1 to 4.4 for selected TOrCs 
High Biotransformation 
Compound Attacked 
fragment* 
Percent 
Removal 
(Mines) 
Predicted reaction 
by “28 days MITI” 
model 
Probability of 
transformation 
Androstenedione Aliphatic alcohol 100 Oxidation 1 
Androsterone Aliphatic alcohol 100 Oxidation 1 
Estradiol Aliphatic alcohol 100 Oxidation 1 
Phenyphenol Aromatic alcohol 100 Aromatic oxidation 0.8758 
Testosterone Aliphatic alcohol 100 Oxidation 1 
Low Biotransformation 
Compound Attacked 
fragment* 
Percent 
Removal 
(Mines) 
Predicted reaction 
by “28 days MITI” 
model 
Probability of 
transformation 
Carbamazepine Aromatic H 15 Amide hydrolysis 0.504 
Diazepam Amide 21 Amide hydrolysis 0.381 
Dilantin Aromatic H 0 Amide hydrolysis 
and aromatic 
oxidation 
0.020 
Primidone Amide 10 Amide hydrolysis 0.352 
*first and second fragment attacked; data extracted from peer-reviewed metabolic pathways 
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Some of the 29 chemicals could not be grouped as being very structurally different from each 
other. TCEP, for instance, is the only chemical in the list having phosphate ester fragments. This 
flame retardant could be compared with other chlorinated flame retardants, such as TCPP and 
TDCPP, if these two were included in a more comprehensive list of TOrCs. Differences on 
degradation for these compounds could then be attributed to the different degree of 
halogenation, and not necessarily the presence of a phosphate ester fragment. This example 
also confirms that considering structural fragments alone might not help in the prediction of 
biodegradation of yet very similar compounds. 
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V. CONCLUSION 
Biotransformation rate constants determined in this study for two different treatment plants 
differed for the same compound. This finding was expected as the facilities operate at different 
conditions (SRT of 5 days and nitrification for Denver Metro; SRT of 11 days and 
nitrification/partially denitrification for Mines Park). Predictions of removal utilizing kbio values 
determined for activated sludge systems from Denver and Mines were limited to properly 
describe the fate of TOrCs in other full-scale treatment plants with similar SRTs. A comparison 
between predicted versus observed removal revealed that generally removal percentages fell 
within specific clusters for each compound, some of them being well predicted if ranges of 
removal were valued. Thus, it is hypothesized that if a more careful selection of treatment 
plants operating at very similar conditions (i.e., SRT, HRT, MLSS, influent concentrations) of 
Denver Metro and Mines Park treatment systems is done, the predicted and observed removal 
data points would agree better. 
A comparison between the outputs of three attenuation models available in Catalogic 
demonstrated that for the 29 TOrCs listed, abiotic degradation pathways are frequently present 
in pathways determined under biotic conditions, with higher probability associated with the 
same reactions. The “28 days MITI (OECD 301C)” model was more complete in terms of 
degradation pathways than the other two models, usually covering all the reactions revealed by 
the other two. Thus, “28 days MITI” model was chosen for the comparison of predicted and 
observed degradation pathways from the literature. Results revealed that the predicted 
outcome was correct for more than 40 percent of the 29 targeted TOrCs. The other 38 percent 
of chemicals from the data set exhibited some degree of lower agreement between predicted 
and observed pathways. 
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Predicted probabilities values from Catalogic for 23 out of the 29 TOrCs were compared with 
observed removal data from the two treatment plants, Denver Metro and Mines Park, and high 
coefficients of determination (R2 = 0.82 and 0.9) for the plots were obtained. These results 
demonstrate the potential of the model “28 days MITI”, combined with peer-reviewed 
degradation pathways, to accurately predict removal of chemicals during activated sludge 
treatment processes.  
Fragments present in a compound are related with likelihood of biodegradation, since 
probabilities predicted in Catalogic models are calculated using functional groups undergoing 
transformations. Another piece of evidence for the relationship between the presence of 
fragments and likelihood of biodegradation is the vast amount of other QSPR models using 
structural fragments as descriptor factors to predict biodegradability of chemicals (van 
Leeuwen, Vermeire et al. 2007). 
The combination of data compiled in this study could be very useful to identify indicator 
compounds that can represent the fate of TOrCs with similar properties and characteristics. 
However, more chemicals should be evaluated to further improve this approach, using 
fragments, probabilities of reactions, and percent removal data. 
Future studies should also take into account degradation products, which can be even more 
toxic and persistent than the parent compound. In this matter, Catalogic has the advantage that 
probabilities of transformation also predict metabolite quantities, and accumulation of certain 
recalcitrant products can be assessed. 
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APPENDIX A: List of 29 selected TOrCs, chemical classes and applications. 
 
 
  
CLASS COMPOUND APPLICATION CLASS COMPOUND APPLICATION
Household Chemical Pharmaceutical
Bisphenol A plasticizer Acetaminophen analgesic
TCEP flame retardant Amitriptyline antidepressant
Personal Care Product Atenolol beta blocker
DEET insecticide Atorvastatin lowers cholesterol
Phenylphenol antimicrobial Carbamazepine antiepileptic
Triclosan antimicrobial Diazepam muscle relaxant
Steroidal Hormone Diclofenac analgesic
Androstendione androgen Dilantin anticonvulsant
Androsterone androgen Gemfibrozil lipid regulator
Estradiol (17β) estrogen Ibuprofen analgesic
Estriol estrogen Meprobamate antianxiety
Estrone estrogen Naproxen analgesic
Ethynylestradiol (17α) estrogen Primidone antiepileptic
Testosterone androgen Risperidone antipsychotic
Stimulant Sulfamethoxazole antibiotic
Caffeine Trimethoprim antibiotic
 
 
APPENDIX B: List of 29 selected TOrCs, CAS numbers, molecular formulas and 
structures 
Compound 
CAS 
number 
Molecular 
Formula 
Structure 
Acetaminophen 103-90-2 C8H9NO2 
 
70 
 
Amitriptyline 
hydrochloride 
549-18-8 C20H24ClN 
 
Androstenedione 63-05-8 C19H26O2 
 
71 
 
Androsterone 53-41-8 C19H30O2 
 
Atenolol 29122-68-7 C14H22N2O3 
 
72 
 
Atorvastatin 134523-00-5 C33H35FN2O5 
 
Bisphenol A 80-05-7 C15H16O2 
 
73 
 
Caffeine 58-08-2 C8H10N4O2 
 
Carbamazepine 298-46-4 C15H12N2O 
 
74 
 
DEET 134-62-3 C12H17NO 
 
Diazepam 439-14-5 C16H13ClN2O 
 
75 
 
Diclofenac 15307-86-5 C14H11Cl2NO2 
 
Dilantin 57-41-0 C15H12N2O2 
 
76 
 
Estradiol (17β) 50-28-2 C18H24O2 
 
Estriol 50-27-1 C18H24O3 
 
77 
 
Estrone 53-16-7 C18H22O2 
 
Ethynylestradiol 
(17α) 
57-63-6 C20H24O2 
 
78 
 
Gemfibrozil 25812-30-0 C15H22O3 
 
Ibuprofen 15687-27-1 C13H18O2 
 
79 
 
Meprobamate 57-53-4 C9H18N2O4 
 
Naproxen 22204-53-1 C14H14O3 
 
80 
 
Phenylphenol 90-43-7 C12H10O 
 
Primidone 125-33-7 C12H14N2O2 
 
81 
 
Risperidone 106266-06-2 C23H27FN4O2 
 
Sulfamethoxazole 723-46-6 C10H11N3O3S 
 
82 
 
TCEP 115-96-8 C6H12Cl3O4P 
 
Testosterone 58-22-0 C19H28O2 
 
83 
 
Triclosan 3380-34-5 C12H7Cl3O2 
 
Trimethoprim 738-70-5 C14H18N4O3 
 
 
 
 
APPENDIX C: Compiled information from literature on removal of selected TOrCs during conventional wastewater treatments 
 
COMPOUND INITIAL CONC % REMOVAL WWTP 
CONDITIONS OF 
EXPERIMENT 
REFERENCE 
INFORMATION ON 
kbio OR Kd? 
Acetaminophen 9900 99.9 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hour MLSSconc 
of 2.5 +-0.1 g/L SRT 10 days 
Radjenovic et al 
2009 
Kd 1160+-692 L/Kg 
 
8140 98.2 
Activated sludge, anoxic 
and aerobic zones 
HRT of 24 hours SRT 13 
days 
Al-Rifai et al 2011 NO 
 
960 99 
Activated sludge with 
biological nutrient 
removal 
HRT of 6 to 8 hours SRT 8 
to 10 days 
Yu et al 2006 NO 
Amitriptyline 
hydrochloride 
750 97.8 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
 
2092 96 
Activated sludge, 
extended aeration, 
denitrification and 
nitrification 
Not determined 
Kasprzyk-Hodern 
et al 2009 
NO 
Androstendione 2200 99.5 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
 
140 93 MBR Not determined Kim et al 2007 NO 
Androsterone 1500 99.3 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
 
2400 and 2040 >99 
Activated sludge, anoxic, 
anaerobic and aerobic 
zones 
Not determined Tan et al 2007 NO 
Atenolol 2000 61.2 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hours 
MLSSconc of 2.5 +-0.1 g/L 
SRT 10 days 
Radjenovic et al 
2009 
Kd 64+-88 L/Kg 
 
540 44 to 62 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6 hours SRT 18.5 
days 
Wick et al 2009 Kbio 1.9+-0.2 L/gSS.d 
85 
 
 
1913ng/L +-410 79 
Activated sludge, non-
aerated denitrification 
and sand filter 
HRT of 6.6 +- 1 hour SSconc 
of 3.9 +-0.6 gCOD/L SRT 8 
to 10 days 
Maurer et al 2007 
Kbio 0.69+-0.05 
L/gCOD.d Kd 38+-33 
L/Kg COD 
 
2545ng/L +- 
174 
73 
Activated sludge, non-
aerated denitrification 
and sand filter 
HRT of 18.4 +- 2.8 hours 
SSconc of 2.3 +-0.3 gCOD/L 
SRT 14.6 d 
Maurer et al 2007 
Kbio 0.69+-0.05 
L/gCOD.d Kd 38+-33 
L/Kg COD 
 
1600 0 
Chemical precipitation 
with FeCl3 and activated 
sludge 
HRT of 2 to 4 hours 
Morasch & Kohn 
2010 
NO 
 
2519 39.4 
Activated sludge, 
denitrification and 
nitrification 
HRT of 16 to 18 hours SRT 
16 to 17 days 
Hollender et al 
2009 
NO 
 
738 to 2883 77 
Primary treatment and 
activated sludge 
HRT of 12 hours Lin et al 2009 NO 
 
2300 84 
Activated sludge, 
biological phosphate 
removal, denitrification 
and nitrification 
HRT of 25 to 35 hours SRT 
12 to 14 days 
Ternes et al 2007 NO 
Atorvastatin 76 51.3 Activated sludge 
HRT of 12 to 18 hours SRT 4 
to 6 days 
Miao & Metcalfe 
2003 
NO 
Bisphenol A 5x10
6
 97.8 
Activated sludge 
constantly aerated 
HRT of 11 hours MLSS of 
3.23 g/L SRT 40 days 
Chen et al 2008 Kd 2 to 2.75 L/Kg 
 
2151 96.5 
Activated sludge, 
phosphorus precipitation, 
denitrification and 
nitrification 
HRT of 13.6 days VSS of 4.7 
g/L SRT 52 days 
Clara et al 2005a, 
2005b 
Kbio 45.2 L/gXVSS.d 
 
1710 10.5 
Activated sludge, 
continuously aerated 
HRT of 1.92 hours VSS of 
3.2 g/L SRT 2 days 
Clara et al 2005a, 
2005b 
Kbio 0.7 L/gXVSS.d 
 
720 82.6 
Activated sludge, 
biological phosphorus 
removal, denitrification 
and nitrification 
HRT of 28.8 hours VSS of 2 
g/L SRT 46 days 
Clara et al 2005a, 
2005b 
Kbio 2.1 L/gXVSS.d 
86 
 
 
23020 91.5 
Activated sludge, anoxic 
and aerobic zones 
HRT of 24 hours SRT 13 
days 
Al-Rifai et al 2011 NO 
 
870 53 
Chemical precipitation 
with FeCl3 and activated 
sludge 
HRT of 2 to 4 hours 
Morasch & Kohn 
2010 
NO 
 
11800 70.5 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
 
590 100 
Activated sludge, 
nitrification and 
phosphorus precipitation 
HRT of 8 hours MLSS 3.2g/L 
SRT 12.6 days 
Fernandez et al 
2007 and Servos 
et al 2005 
NO 
 
448 92.4 Activated sludge 
HRT of 8.6 hours SRT 3.8 
days 
Nakada et al 2006 NO 
 
188 92.4 Activated sludge 
HRT of 9.4 hours SRT 5.8 
days 
Nakada et al 2006 NO 
 
470 95.9 
Activated sludge, 
continuously aerated 
HRT of 1.2 hours MLSS 2.18 
g/L SRT 1.7 days 
Drewes et al 2005 NO 
 
281 95 
Activated sludge, 
denitrification and 
nitrification 
HRT of 2.3 hours MLSS 3.66 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
328 95.7 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5 hours MLSS 2 g/L 
SRT 10 days 
Drewes et al 2005 NO 
 
530 90.6 
Activated sludge, 
nitrification 
HRT of 6.8 hours MLSS 2.23 
g/L SRT 4.4 days 
Drewes et al 2005 NO 
 
323 91.3 
Activated sludge, 
denitrification and 
nitrification 
HRT of 7 hours MLSS 2g/L 
SRT 7 days 
Drewes et al 2005 NO 
Caffeine 1800 49.6 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
 
5173 to 17500 100 
Primary treatment and 
activated sludge 
HRT of 12 hours Lin et al 2009 NO 
 
7370 75 
Primary treatment and 
activated sludge 
HRT of 12 hours SRT 1.5 
days 
Santos et al 2009 NO 
87 
 
 
4870 44 
Primary treatment and 
activated sludge 
HRT of 17 hours SRT 2.7 
days 
Santos et al 2009 NO 
 
7090 64 
Primary treatment and 
activated sludge 
HRT of 12 hours SRT 1.9 
days 
Santos et al 2009 NO 
 
5340 55 
Primary treatment and 
activated sludge 
HRT of 16 hours SRT 5.1 
days 
Santos et al 2009 NO 
 
3361 99.6 
Primary treatment and 
activated sludge 
Not determined 
Spongberg & 
Witter 2008 
NO 
 
42000 64 Activated sludge Not determined 
Benotti & 
Brownawell 2007 
NO 
 
118000 89.8 
Primary treatment, 
activated sludge, final 
clarification 
Not determined Gomez et al 2007 NO 
 
9680 98.9 MBR Not determined Kim et al 2007 NO 
  
85 
Activated sludge with 
high purity oxigen input 
HRT of 2.3 hours MLSS 1.6 
g/L SRT 1 day 
Stephenson & 
Oppenheimer 
2007 
NO 
  
99 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6.2 hours MLSS 1.2 
g/L SRT 5.3 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
98 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5.5 hours MLSS 2.6 
g/L SRT 6 to 11 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
98 
Activated sludge, 
denitrification and 
nitrification 
HRT of 30 hours MLSS 2.1 
g/L SRT 12 to 16 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
99 
Activated sludge, 
extended aeration, 
denitrification and 
nitrification 
HRT of 24 hours MLSS 
4.6g/L SRT 20 to 30 days 
Stephenson & 
Oppenheimer 
2007 
NO 
 
82000 99.7 
Activated sludge, 
biological phosphate 
removal, denitrification 
and nitrification 
HRT of 25 to 35 hours SRT 
12 to 14 days 
Ternes et al 2007 NO 
88 
 
 
41100 to 32800 99.9 
Activated sludge, 
denitrification and 
nitrification 
Not determined 
Thomas & Foster 
2005 
NO 
Carbamazepine 156 <10 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hour MLSSconc 
of 2.5 +-0.1 g/L SRT 10 days 
Radjenovic et al 
2009 
Kd 135+-39 L/Kg 
 
660 0 to 20 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6 hours SRT 18.5 
days 
Wick et al 2009 
Kbio  =<  0.10 L/gSS.d       
Kd 17+-1 L/KgSS 
 
704 -35.2 
Activated sludge, 
phosphorus precipitation, 
denitrification and 
nitrification 
HRT of 13.6 days VSS of 4.7 
g/L SRT 52 days 
Clara et al 2005a, 
2005b 
Kbio 0.1 L/gXVSS.d 
 
670 -3 
Activated sludge, 
continuously aerated 
HRT of 1.92 hours VSS of 
3.2 g/L SRT 2 days 
Clara et al 2005a, 
2005b 
Kbio -0.1 L/gXVSS.d 
 
325 -43 
Activated sludge, 
biological phosphorus 
removal, denitrification 
and nitrification 
HRT of 28.8 hours VSS of 2 
g/L SRT 46 days 
Clara et al 2005a, 
2005b 
Kbio -0.1 L/gXVSS.d 
 
700 0 to 10 
Activated sludge, 
phosporus precipitation, 
denitrification and 
nitrification 
HRT of 7.3 hours MLSS 
3.5g/L SRT 10 to 12 days 
Joss et al 2005 
Sorbed amount not 
relevant; Kd 1.2 to 1.4 
L/Kg (Ternes et al 
2004) 
 
1480 76.4 
Activated sludge, anoxic 
and aerobic zones 
HRT of 24 hours SRT 13 
days 
Al-Rifai et al 2011 NO 
 
2500 15 
Chemical precipitation 
with FeCl3 and activated 
sludge 
HRT of 2 to 4 hours 
Morasch & Kohn 
2010 
NO 
 
509 -47 to 28 
Activated sludge, 
denitrification and 
nitrification 
HRT of 16 to 18 hours SRT 
16 to 17 days 
Hollender et al 
2009 
NO 
 
82 to 357 40 
Primary treatment and 
activated sludge 
HRT of 12 hours Lin et al 2009 NO 
89 
 
 
530 11 
Primary treatment and 
activated sludge 
HRT of 12 hours SRT 1.5 
days 
Santos et al 2009 NO 
 
470 7 
Primary treatment and 
activated sludge 
HRT of 17 hours SRT 2.7 
days 
Santos et al 2009 NO 
 
410 7 
Primary treatment and 
activated sludge 
HRT of 12 hours SRT 1.9 
days 
Santos et al 2009 NO 
 
490 8 
Primary treatment and 
activated sludge 
HRT of 16 hours SRT 5.1 
days 
Santos et al 2009 NO 
 
81.9 43.3 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
 
2000 0 
Activated sludge, 
biological phosphate 
removal, denitrification 
and nitrification 
HRT of 25 to 35 hours SRT 
12 to 14 days 
Ternes et al 2007 NO 
 
55.9 
- 23.5 to 
58.1 
Activated sludge 
HRT of 8.6 hours SRT 3.8 
days 
Nakada et al 2006 NO 
 
43.1 -53.6 to 5.98 Activated sludge HRT of 8 hours SRT 4.6 days Nakada et al 2006 NO 
 
54.3 -56.7 to 47.3 Activated sludge HRT of 7.1 hours SRT 5 days Nakada et al 2006 NO 
 
173.3 -17.3 to 39.7 Activated sludge 
HRT of 8.9 hours SRT 8.4 
days 
Nakada et al 2006 NO 
 
700 0 
Activated sludge and 
chlorine disinfection 
HRT of 15 hours SRT 5.5 
days 
Metcalfe et al 
2003 
NO 
 
600 -33.3 
Activated sludge and 
chlorine disinfection 
HRT of 14 hours SRT 2.7 
days 
Metcalfe et al 
2003 
NO 
 
1000 50 
Activated sludge and UV 
disinfection 
HRT of 14 hours SRT 4.1 
days 
Metcalfe et al 
2003 
NO 
 
1200 -41.7 Activated sludge 
HRT of 12 hours SRT 2.7 
days 
Metcalfe et al 
2003 
NO 
DEET 1050 4.6 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
 
18 0 MBR Not determined Kim et al 2007 NO 
  
21 
Activated sludge with 
high purity oxigen input 
HRT of 2.3 hours MLSS 1.6 
g/L SRT 1 day 
Stephenson & 
Oppenheimer 
NO 
90 
 
2007 
  
23 
Activated sludge, 
denitrification and 
nitrification 
HRT of 3.7 hours MLSS 2.3 
g/L SRT 4 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
56 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6.2 hours MLSS 1.2 
g/L SRT 5.3 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
84 
Activated sludge, 
denitrification and 
nitrification 
HRT of 30 hours MLSS 2.1 
g/L SRT 12 to 16 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
91 
Activated sludge, 
extended aeration, 
denitrification and 
nitrification 
HRT of 24 hours MLSS 
4.6g/L SRT 20 to 30 days 
Stephenson & 
Oppenheimer 
2007 
NO 
Diazepam 0 - 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6 hours SRT 18.5 
days 
Wick et al 2009 
Kbio  =<   0.16 L/gSS.d      
Kd 53+-1 L/KgSS 
Diclofenac 1320 21.8 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hour MLSSconc 
of 2.5 +-0.1 g/L SRT 10 days 
Radjenovic et al 
2009 
Kd 118+-95 L/Kg 
 
3190 47.3 
Activated sludge, 
phosphorus precipitation, 
denitrification and 
nitrification 
HRT of 13.6 days VSS of 4.7 
g/L SRT 52 days 
Clara et al 2005a, 
2005b 
Kbio 0 L/gXVSS.d 
 
1400 7.1 
Activated sludge, 
continuously aerated 
HRT of 1.92 hours VSS of 
3.2 g/L SRT 2 days 
Clara et al 2005a, 
2005b 
Kbio 0.8 L/gXVSS.d 
 
905 13.8 
Activated sludge, 
biological phosphorus 
removal, denitrification 
and nitrification 
HRT of 28.8 hours VSS of 2 
g/L SRT 46 days 
Clara et al 2005a, 
2005b 
Kbio 0.1 L/gXVSS.d 
 
1500 20 to 35 
Activated sludge, 
phosporus precipitation, 
denitrification and 
HRT of 7.3 hours MLSS 
3.5g/L SRT 10 to 12 days 
Joss et al 2005, 
2006 
Kbio =< 0.1 L/gSS.d 
91 
 
nitrification 
 
650 57 
Activated sludge, anoxic 
and aerobic zones 
HRT of 24 hours SRT 13 
days 
Al-Rifai et al 2011 NO 
 
530 0 
Chemical precipitation 
with FeCl3 and activated 
sludge 
HRT of 2 to 4 hours 
Morasch & Kohn 
2010 
NO 
 
1466 25 
Activated sludge, 
denitrification and 
nitrification 
HRT of 16 to 18 hours SRT 
16 to 17 days 
Hollender et al 
2009 
NO 
 
3 to 437 0 
Primary treatment and 
activated sludge 
HRT of 12 hours Lin et al 2009 NO 
 
2000 33 
Activated sludge, 
biological phosphate 
removal, denitrification 
and nitrification 
HRT of 25 to 35 hours SRT 
12 to 14 days 
Ternes et al 2007 NO 
 
978 65 
Trickling filter and 
activated sludge 
HRT of 12.5 hours SRT 2.4 
days 
Roberts and 
Thomas 2006 
NO 
 
110 18 
Activated sludge with 
biological nutrient 
removal 
HRT of 6 to 8 hours SRT 8 
to 10 days 
Yu et al 2006 NO 
 
1300 >81 
Activated sludge and 
chlorine disinfection 
HRT of 14 hours SRT 2.7 
days 
Metcalfe et al 
2003 
NO 
Dilantin 1850 5.4 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
 
450 44 
Activated sludge with 
biological nutrient 
removal 
HRT of 6 to 8 hours SRT 8 
to 10 days 
Yu et al 2006 NO 
Estradiol (17β) 7.6 >97 
Activated sludge, 
phosporus precipitation, 
denitrification and 
nitrification 
HRT of 7.3 hours MLSS 
3.5g/L SRT 10 to 12 days 
Joss et al 2004 Kbio 985+-74 L/gSS.d 
92 
 
 
22 96 
Activated sludge, anoxic 
and aerobic zones 
HRT of 4 hours, SRT 16 days Braga et al 2005 
1% of the total mass 
load found in the 
sludge 
 
11.7 >90 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
 
23.2 87.3 Activated sludge 
HRT of 8.6 hours SRT 3.8 
days 
Nakada et al 2006 NO 
 
22.9 97.9 Activated sludge 
HRT of 9.4 hours SRT 5.8 
days 
Nakada et al 2006 NO 
 
19.9 68.8 
Activated sludge, 
biological phosphorus 
removal and nitrification 
HRT of 13.7 hours MLSS 1.9 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
37.5 98.4 
Activated sludge, 
phosphorus precipitation 
and nitrification 
HRT of 5.5 hours MLSS 2.32 
g/L SRT 8.5 days 
Drewes et al 2005 NO 
 
24.5 82 
Activated sludge, 
continuously aerated 
HRT of 1.2 hours MLSS 2.18 
g/L SRT 1.7 days 
Drewes et al 2005 NO 
 
37.6 98.4 
Activated sludge, 
denitrification and 
nitrification 
HRT of 2.3 hours MLSS 3.66 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
15.3 60.8 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5 hours MLSS 2 g/L 
SRT 10 days 
Drewes et al 2005 NO 
 
25.9 97.3 
Activated sludge, 
nitrification 
HRT of 6.8 hours MLSS 2.23 
g/L SRT 4.4 days 
Drewes et al 2005 NO 
 
13.1 95.3 
Activated sludge, 
denitrification and 
nitrification 
HRT of 7 hours MLSS 2g/L 
SRT 7 days 
Drewes et al 2005 NO 
 
22 96.8 
Activated sludge and 
polymer, partial 
nitrification, phosphorus 
precipitation 
HRT of 6.6 hours MLSS 2g/L 
SRT 9.6 days 
Servos et al 2005 NO 
 
24 39.5 
Activated sludge, 
phosporus precipitation 
HRT of 6.7 hours MLSS 
2.7g/L SRT 2.7 days 
Servos et al 2005 NO 
93 
 
 
26 98.3 
Activated sludge, partial 
nitrification, phosporus 
precipitation 
HRT of 8 hours MLSS 
1.86g/L SRT 4.1 days 
Servos et al 2005 NO 
 
17.4 +- 1.7 58.6 
Activated sludge, 
denitrification and 
nitrification 
HRT of 10 hours SS 3g/L 
SRT > 10 days 
Cargouët et al 
2004 and Tallec et 
al 2008 
NO 
 
12 87 Activated sludge 
HRT of 12 to 14 hours SRT 
15 to 16 days 
Baronti et al 2000 
& Johnson et al 
2000 
NO 
 
14 92 Activated sludge HRT of 11 hours SRT 6 days 
Johnson et al 
2000 
NO 
 
0.7 98 Activated sludge 
HRT of 18 hours SRT 11 
days 
Johnson et al 
2000 
NO 
Estriol 15.9 97.5 
Activated sludge, 
biological phosphorus 
removal and nitrification 
HRT of 13.7 hours MLSS 1.9 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
19.2 97.9 
Activated sludge, 
phosphorus precipitation 
and nitrification 
HRT of 5.5 hours MLSS 2.32 
g/L SRT 8.5 days 
Drewes et al 2005 NO 
 
15.8 97.5 
Activated sludge, 
continuously aerated 
HRT of 1.2 hours MLSS 2.18 
g/L SRT 1.7 days 
Drewes et al 2005 NO 
 
29.9 98.7 
Activated sludge, 
denitrification and 
nitrification 
HRT of 2.3 hours MLSS 3.66 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
38.3 98.2 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5 hours MLSS 2 g/L 
SRT 10 days 
Drewes et al 2005 NO 
 
2.7 85.2 
Activated sludge, 
nitrification 
HRT of 6.8 hours MLSS 2.23 
g/L SRT 4.4 days 
Drewes et al 2005 NO 
 
15.2 +- 1.4 67.1 
Activated sludge, 
denitrification and 
nitrification 
HRT of 10 hours SS 3g/L 
SRT > 10 days 
Cargouët et al 
2004 and Tallec et 
al 2008 
NO 
 
133 99.8 Activated sludge 
HRT of 8.6 hours SRT 3.8 
days 
Nakada et al 2006 NO 
94 
 
 
255 99.8 Activated sludge 
HRT of 9.4 hours SRT 5.8 
days 
Nakada et al 2006 NO 
 
96.2 99.3 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
 
80 95 Activated sludge 
HRT of 12 to 14 hours SRT 
15 to 16 days 
Baronti et al 2000 
& Johnson et al 
2000 
NO 
Estrone 54.8 85 
Activated sludge, anoxic 
and aerobic zones 
HRT of 4 hours SRT 16 days Braga et al 2005 
9% of the total mass 
load found in the 
sludge 
 
24 96 
Activated sludge, 
phosporus precipitation, 
denitrification and 
nitrification 
HRT of 7.3 hours MLSS 
3.5g/L SRT 10 to 12 days 
Joss et al 2004 Kbio 202+-27 L/gSS.d 
 
9 -100 
Activated sludge, 
nitrification and 
phosphorus precipitation 
HRT of 8 hours MLSS 3.2g/L 
SRT 12.6 days 
Fernandez et al 
2007 and Servos 
et al 2005 
NO 
 
49.1 27.5 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
 
155 84.1 Activated sludge 
HRT of 8.6 hours SRT 3.8 
days 
Nakada et al 2006 NO 
 
28.7 90.3 Activated sludge 
HRT of 9.4 hours SRT 5.8 
days 
Nakada et al 2006 NO 
 
41 98.5 
Activated sludge, 
biological phosphorus 
removal and nitrification 
HRT of 13.7 hours MLSS 1.9 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
42 97.6 
Activated sludge, 
phosphorus precipitation 
and nitrification 
HRT of 5.5 hours MLSS 2.32 
g/L SRT 8.5 days 
Drewes et al 2005 NO 
 
60 70.5 
Activated sludge, 
continuously aerated 
HRT of 1.2 hours MLSS 2.18 
g/L SRT 1.7 days 
Drewes et al 2005 NO 
 
60.3 16.4 
Activated sludge, 
denitrification and 
nitrification 
HRT of 2.3 hours MLSS 3.66 
g/L SRT 10 days 
Drewes et al 2005 NO 
95 
 
 
65.2 83 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5 hours MLSS 2 g/L 
SRT 10 days 
Drewes et al 2005 NO 
 
39.4 30.2 
Activated sludge, 
nitrification 
HRT of 6.8 hours MLSS 2.23 
g/L SRT 4.4 days 
Drewes et al 2005 NO 
 
80.3 79.6 
Activated sludge, 
denitrification and 
nitrification 
HRT of 7 hours MLSS 2g/L 
SRT 7 days 
Drewes et al 2005 NO 
 
45 72.7 
Activated sludge and 
polymer, partial 
nitrification, phosphorus 
precipitation 
HRT of 6.6 hours MLSS 2g/L 
SRT 9.6 days 
Servos et al 2005 NO 
 
62 -54.8 
Activated sludge, 
phosporus precipitation 
HRT of 6.7 hours MLSS 
2.7g/L SRT 2.7 days 
Servos et al 2005 NO 
 
53 85.4 
Activated sludge, partial 
nitrification, phosporus 
precipitation 
HRT of 8 hours MLSS 
1.86g/L SRT 4.1 days 
Servos et al 2005 NO 
 
15.2 +- 1.8 57.2 
Activated sludge, 
denitrification and 
nitrification 
HRT of 10 hours SS 3g/L 
SRT > 10 days 
Cargouët et al 
2004 and Tallec et 
al 2008 
NO 
 
52 61 Activated sludge 
HRT of 12 to 14 hours SRT 
15 to 16 days 
Baronti et al 2000 
& Johnson et al 
2000 
NO 
 
11 to 42 64 to 75 Activated sludge HRT of 11 hours SRT 6 days 
Johnson et al 
2000 
NO 
 
18 to 100 94 to 98 Activated sludge 
HRT of 18 hours SRT 11 
days 
Johnson et al 
2000 
NO 
Ethinylestradiol 
(17α) 
3 >66 
Activated sludge, 
phosphorus precipitation, 
denitrification and 
nitrification 
HRT of 13.6 days VSS of 4.7 
g/L SRT 52 days 
Clara et al 2005b Kbio 1.9 L/gXVSS.d 
 
8 37.5 
Activated sludge, 
continuously aerated 
HRT of 1.92 hours VSS of 
3.2 g/L SRT 2 days 
Clara et al 2005b Kbio 2.8 L/gXVSS.d 
96 
 
 
70 >98 
Activated sludge, 
biological phosphorus 
removal, denitrification 
and nitrification 
HRT of 28.8 hours VSS of 2 
g/L SRT 46 days 
Clara et al 2005b Kbio 29.1 L/gXVSS.d 
 
4.3 94 
Activated sludge, 
phosporus precipitation, 
denitrification and 
nitrification 
HRT of 7.3 hours MLSS 
3.5g/L SRT 10 to 12 days 
Joss et al 2004 Kbio 9.2+-2 L/gSS.d 
 
1.9 63.2 
Activated sludge, 
biological phosphorus 
removal and nitrification 
HRT of 13.7 hours MLSS 1.9 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
9.1 92.3 
Activated sludge, 
phosphorus precipitation 
and nitrification 
HRT of 5.5 hours MLSS 2.32 
g/L SRT 8.5 days 
Drewes et al 2005 NO 
 
14.4 71.5 
Activated sludge, 
continuously aerated 
HRT of 1.2 hours MLSS 2.18 
g/L SRT 1.7 days 
Drewes et al 2005 NO 
 
7.1 +- 0.9 38 
Activated sludge, 
denitrification and 
nitrification 
HRT of 10 hours SS 3g/L 
SRT > 10 days 
Cargouët et al 
2004 and Tallec et 
al 2008 
NO 
 
3 85 Activated sludge 
HRT of 12 to 14 hours SRT 
15 to 16 days 
Baronti et al 2000 
& Johnson et al 
2000 
NO 
Gemfibrozil 3080 
lower than 
10 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hour MLSSconc 
of 2.5 +-0.1 g/L SRT 10 days 
Radjenovic et al 
2009 
Kd 19.3+-9.3 L/Kg 
 
2420 71.5 
Activated sludge, anoxic 
and aerobic zones 
HRT of 24 hours SRT 13 
days 
Al-Rifai et al 2011 NO 
 
410 68 
Activated sludge with 
biological nutrient 
removal 
HRT of 6 to 8 hours SRT 8 
to 10 days 
Yu et al 2006 NO 
 
700 >92.8 
Activated sludge and UV 
disinfection 
HRT of 14 hours SRT 4.1 
days 
Metcalfe et al 
2003 
NO 
97 
 
Ibuprofen 21700 99.1 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hour MLSSconc 
of 2.5 +-0.1 g/L SRT 10 days 
Radjenovic et al 
2009 
Kd 0.0 L/Kg 
 
12000 96 Activated sludge 
HRT of 6.5 hours MLSS 
2.33g/L SRT 9.5 days 
Smook et al 2008 Kbio 6.8+-3.3 L/gSS.d 
 
9000 99.8 Activated sludge 
HRT of 14.2 hours MLSS 
2.33g/L SRT 9.5 days 
Smook et al 2008 Kbio 6.8+-3.3 L/gSS.d 
 
2000 >90 
Activated sludge, 
phosporus precipitation, 
denitrification and 
nitrification 
HRT of 7.3 hours MLSS 
3.5g/L SRT 10 to 12 days 
Joss et al 2005, 
2006 
Kbio 21 to 35 L/gSS.d 
 
2448 99.2 
Activated sludge, 
phosphorus precipitation, 
denitrification and 
nitrification 
HRT of 13.6 days VSS of 4.7 
g/L SRT 52 days 
Clara et al 2005a, 
2005b 
Kbio 29 L/gXVSS.d 
 
1200 98 
Activated sludge, 
biological phosphorus 
removal, denitrification 
and nitrification 
HRT of 28.8 hours VSS of 2 
g/L SRT 46 days 
Clara et al 2005a, 
2005b 
Kbio 20.1 L/gXVSS.d 
 
10340 96.6 
Activated sludge, anoxic 
and aerobic zones 
HRT of 24 hours SRT 13 
days 
Al-Rifai et al 2011 NO 
 
3860 98 
Activated sludge, 
denitrification and 
nitrification 
HRT of 16 to 18 hours SRT 
16 to 17 days 
Hollender et al 
2009 
NO 
 
711 to 17933 56 
Primary treatment and 
activated sludge 
HRT of 12 hours Lin et al 2009 NO 
 
69700 87 
Primary treatment and 
activated sludge 
HRT of 12 hours SRT 1.5 
days 
Santos et al 2009 NO 
 
84400 84 
Primary treatment and 
activated sludge 
HRT of 17 hours SRT 2.7 
days 
Santos et al 2009 NO 
 
105000 80 
Primary treatment and 
activated sludge 
HRT of 12 hours SRT 1.9 
days 
Santos et al 2009 NO 
 
115000 87 
Primary treatment and 
activated sludge 
HRT of 16 hours SRT 5.1 
days 
Santos et al 2009 NO 
98 
 
 
785 98.8 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
  
84 
Activated sludge with 
high purity oxigen input 
HRT of 2.3 hours MLSS 1.6 
g/L SRT 1 day 
Stephenson & 
Oppenheimer 
2007 
NO 
  
43 
Activated sludge, 
denitrification and 
nitrification 
HRT of 3.7 hours MLSS 2.3 
g/L SRT 4 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
89 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6.2 hours MLSS 1.2 
g/L SRT 5.3 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
80 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5.5 hours MLSS 2.6 
g/L SRT 6 to 11 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
85 
Activated sludge, 
denitrification and 
nitrification 
HRT of 30 hours MLSS 2.1 
g/L SRT 12 to 16 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
94 
Activated sludge, 
extended aeration, 
denitrification and 
nitrification 
HRT of 24 hours MLSS 
4.6g/L SRT 20 to 30 days 
Stephenson & 
Oppenheimer 
2007 
NO 
 
3400 96 
Activated sludge, 
biological phosphate 
removal, denitrification 
and nitrification 
HRT of 25 to 35 hours SRT 
12 to 14 days 
Ternes et al 2007 NO 
 
909 84.3 to 96.1 Activated sludge 
HRT of 8.6 hours SRT 3.8 
days 
Nakada et al 2006 NO 
 
592.5 95.5 to 97.2 Activated sludge HRT of 8 hours SRT 4.6 days Nakada et al 2006 NO 
 
578.3 92.8 to 99.7 Activated sludge HRT of 7.1 hours SRT 5 days Nakada et al 2006 NO 
 
595 96.7 to 99.5 Activated sludge 
HRT of 8.9 hours SRT 8.4 
days 
Nakada et al 2006 NO 
 
30871 +- 2893 51.8 
Trickling filter and 
activated sludge 
HRT of 12.5 hours SRT 2.4 
days 
Roberts and 
Thomas 2006 
NO 
99 
 
 
1900 87 
Activated sludge with 
biological nutrient 
removal 
HRT of 6 to 8 hours SRT 8 
to 10 days 
Yu et al 2006 NO 
 
27300 90.1 
Activated sludge and 
chlorine disinfection 
HRT of 15 hours SRT 5.5 
days 
Metcalfe et al 
2003 
NO 
 
58200 89.3 
Activated sludge and 
chlorine disinfection 
HRT of 14 hours SRT 2.7 
days 
Metcalfe et al 
2003 
NO 
 
39100 99.9 
Activated sludge and UV 
disinfection 
HRT of 23 hours SRT 12.6 
Metcalfe et al 
2003 
NO 
 
27900 80.6 Activated sludge 
HRT of 12 hours SRT 2.7 
days 
Metcalfe et al 
2003 
NO 
Meprobamate 2000 14.5 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
Naproxen 1500 70 to 80 
Activated sludge, 
phosporus precipitation, 
denitrification and 
nitrification 
HRT of 7.3 hours MLSS 
3.5g/L SRT 10 to 12 days 
Joss et al 2005, 
2006 
Kbio 1 to 1.9 L/gSS.d 
 
7840 98.1 
Activated sludge, anoxic 
and aerobic zones 
HRT of 24 hours SRT 13 
days 
Al-Rifai et al 2011 NO 
 
587 56 
Activated sludge, 
denitrification and 
nitrification 
HRT of 16 to 18 hours SRT 
16 to 17 days 
Hollender et al 
2009 
NO 
 
463 71.8 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hour MLSSconc 
of 2.5 +-0.1 g/L SRT 10 days 
Radjenovic et al 
2009 
NO 
 
4830 43 
Primary treatment and 
activated sludge 
HRT of 12 hours SRT 1.5 
days 
Santos et al 2009 NO 
 
8070 71 
Primary treatment and 
activated sludge 
HRT of 17 hours SRT 2.7 
days 
Santos et al 2009 NO 
 
4690 48 
Primary treatment and 
activated sludge 
HRT of 12 hours SRT 1.9 
days 
Santos et al 2009 NO 
 
4280 60 
Primary treatment and 
activated sludge 
HRT of 16 hours SRT 5.1 
days 
Santos et al 2009 NO 
100 
 
 
206 58.8 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
 
134.2 22.5 to 64.9 Activated sludge 
HRT of 8.6 hours SRT 3.8 
days 
Nakada et al 2006 NO 
 
92.8 45.6 to 75.1 Activated sludge HRT of 8 hours SRT 4.6 days Nakada et al 2006 NO 
 
62 36.9 to 82.9 Activated sludge HRT of 7.1 hours SRT 5 days Nakada et al 2006 NO 
 
150.4 14.7 to 72.1 Activated sludge 
HRT of 8.9 hours SRT 8.4 
days 
Nakada et al 2006 NO 
 
3200 88 
Activated sludge with 
biological nutrient 
removal 
HRT of 6 to 8 hours SRT 8 
to 10 days 
Yu et al 2006 NO 
 
30000 >99.7 
Activated sludge and 
chlorine disinfection 
HRT of 15 hours SRT 5.5 
days 
Metcalfe et al 
2003 
NO 
 
42000 >99.8 
Activated sludge and 
chlorine disinfection 
HRT of 14 hours SRT 2.7 
days 
Metcalfe et al 
2003 
NO 
 
63000 >99.9 
Activated sludge and UV 
disinfection 
HRT of 14 hours SRT 4.1 
days 
Metcalfe et al 
2003 
NO 
 
16000 >99.3 
Activated sludge and UV 
disinfection 
HRT of 23 hours SRT 12.6 
days 
Metcalfe et al 
2003 
NO 
Phenylphenol 900 80 
Activated sludge with 
biological nutrient 
removal 
HRT of 6 to 8 hours SRT 8 
to 10 days 
Yu et al 2006 NO 
Primidone 230 40 to 53 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6 hours SRT 18.5 
days 
Wick et al 2009 
Kbio  =<   0.1 L/gSS.d         
Kd 7+-1 L/KgSS 
 
1470 64.6 
Activated sludge, anoxic 
and aerobic zones 
HRT of 24 hours SRT 13 
days 
Al-Rifai et al 2011 NO 
 
1850 12.4 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
 
200 0 
Chemical precipitation 
with FeCl3 and activated 
sludge 
HRT of 2 to 4 hours 
Morasch & Kohn 
2010 
NO 
101 
 
 
81 20 
Activated sludge, 
denitrification and 
nitrification 
HRT of 16 to 18 hours SRT 
16 to 17 days 
Hollender et al 
2009 
NO 
Risperidone 1500 95.8 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
Sulfamethoxazole 93 73.8 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hour MLSSconc 
of 2.5 +-0.1 g/L SRT 10 days 
Radjenovic et al 
2009 
Kd 77+-60 L/Kg 
 
300 and 600 for 
N
4
AcSMX 
55 
Activated sludge, 
phosporus precipitation, 
denitrification and 
nitrification 
HRT of 7.3 hours MLSS 
3.5g/L SRT 10 to 12 days 
Joss et al 2005, 
2006 
Kbio 5.9 to 7.6L/gSS.d 
for N
4
-acetyl 
sulfamethoxazole 
 
144 to 674 
>44.4 to 
71.4 
Primary treatment, 
activated sludge with 
nitrogen removal and 
sand filtration 
HRT of 24 hours SRT 15 
days 
Lindberg et al 
2005 
Chemical was not 
found in the sludge 
 
337 10 
Primary treatment and 
activated sludge with 
nitrogen removal 
HRT of 16 hours SRT 11 
days 
Lindberg et al 
2005 
Chemical was not 
found in the sludge 
 
343 and 518 for 
N
4
AcSMX 
50 to 53 
Activated sludge, 
denitrification and 
nitrification 
HRT of 15 hours, Ssconc 
3g/L, SRT 10 to 12 days 
Gobel et al 2004, 
2005, 2007 
Kd 256+-169 L/kg 
 
641 and 943 for 
N
4
AcSMX 
61 to 76 
Activated sludge, 
denitrification and 
nitrification 
HRT of 31 hours, Ssconc 
3g/L, SRT 21 to 25 days 
Gobel et al 2004, 
2005, 2007 
Kd 256+-169 L/kg 
 
55 lower than 0 
Chemical precipitation 
with FeCl3 and activated 
sludge 
HRT of 2 to 4 hours 
Morasch & Kohn 
2010 
NO 
 
292 32.5 
Activated sludge, 
denitrification and 
nitrification 
HRT of 16 to 18 hours SRT 
16 to 17 days 
Hollender et al 
2009 
NO 
 
179 to 1760 26 
Primary treatment and 
activated sludge 
HRT of 12 hours Lin et al 2009 NO 
102 
 
 
104 61.6 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
 
820 24 
Activated sludge, 
biological phosphate 
removal, denitrification 
and nitrification 
HRT of 25 to 35 hours SRT 
12 to 14 days 
Ternes et al 2007 NO 
 
480 61.5 Activated sludge 
HRT of 11 hours SRT 12.5 
days 
Watkinson et al 
2007 
NO 
 
75 32 
Activated sludge, 
biological phosphorus 
removal, denitrification 
and nitrification 
HRT of 28.8 hours VSS of 2 
g/L SRT 46 days 
Clara et al 2005 NO 
TCEP 
 
3 to 6 
Activated sludge, 
denitrification and 
nitrification 
HRT of 3.7 hours MLSS 2.3 
g/L SRT 4 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
0 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6.2 hours MLSS 1.2 
g/L SRT 5.3 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
0 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5.5 hours MLSS 2.6 
g/L SRT 6 to 11 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
50 
Activated sludge, 
extended aeration, 
denitrification and 
nitrification 
HRT of 24 hours MLSS 
4.6g/L SRT 20 to 30 days 
Stephenson & 
Oppenheimer 
2007 
NO 
Testosterone 42 100 
Activated sludge, 
nitrification and 
phosphorus precipitation 
HRT of 8 hours MLSS 3.2g/L 
SRT 12.6 days 
Fernandez et al 
2007 and Servos 
et al 2005 
NO 
 
135.8 95.4 
Activated sludge, 
biological phosphorus 
removal and nitrification 
HRT of 13.7 hours MLSS 1.9 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
35.1 96.3 
Activated sludge, 
phosphorus precipitation 
and nitrification 
HRT of 5.5 hours MLSS 2.32 
g/L SRT 8.5 days 
Drewes et al 2005 NO 
103 
 
 
80.8 97.6 
Activated sludge, 
continuously aerated 
HRT of 1.2 hours MLSS 2.18 
g/L SRT 1.7 days 
Drewes et al 2005 NO 
 
79.1 99 
Activated sludge, 
denitrification and 
nitrification 
HRT of 2.3 hours MLSS 3.66 
g/L SRT 10 days 
Drewes et al 2005 NO 
 
49.1 91.6 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5 hours MLSS 2 g/L 
SRT 10 days 
Drewes et al 2005 NO 
 
45.2 99 
Activated sludge, 
nitrification 
HRT of 6.8 hours MLSS 2.23 
g/L SRT 4.4 days 
Drewes et al 2005 NO 
 
188 98.7 
Activated sludge, 
denitrification and 
nitrification 
HRT of 7 hours MLSS 2g/L 
SRT 7 days 
Drewes et al 2005 NO 
Triclosan 3380 66.3 Activated sludge HRT of 6 hours 
McAvoy et al 
2002 
26.6% removed with 
the sludge 
 
7000 34.1 Activated sludge HRT of 3 hours 
McAvoy et al 
2002 
60% removed with the 
sludge 
 
550 91.8 MBR 
HRT of 24 hours MLSS 
8.6g/L SRT 70 days 
Tadkaew et al 
2011 
NO 
 
316 50 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
  
64 and 72 
Activated sludge with 
high purity oxigen input 
HRT of 2.3 hours MLSS 1.6 
g/L SRT 1 day 
Stephenson & 
Oppenheimer 
2007 
NO 
  
60 and 82 
Activated sludge, 
denitrification and 
nitrification 
HRT of 6.2 hours MLSS 1.2 
g/L SRT 5.3 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
30, 81 and 
89 
Activated sludge, 
denitrification and 
nitrification 
HRT of 5.5 hours MLSS 2.6 
g/L SRT 6 to 11 days 
Stephenson & 
Oppenheimer 
2007 
NO 
  
96 
Activated sludge, 
denitrification and 
nitrification 
HRT of 30 hours MLSS 2.1 
g/L SRT 12 to 16 days 
Stephenson & 
Oppenheimer 
2007 
NO 
104 
 
  
87 
Activated sludge, 
extended aeration, 
denitrification and 
nitrification 
HRT of 24 hours MLSS 
4.6g/L SRT 20 to 30 days 
Stephenson & 
Oppenheimer 
2007 
NO 
 
367.5 46.2 to 65.2 Activated sludge 
HRT of 8.6 hours SRT 3.8 
days 
Nakada et al 2006 NO 
 
437 70.2 to 78.9 Activated sludge HRT of 8 hours SRT 4.6 days Nakada et al 2006 NO 
 
598 77.2 to 93.4 Activated sludge HRT of 7.1 hours SRT 5 days Nakada et al 2006 NO 
 
642.8 58.2 to 75.4 Activated sludge 
HRT of 8.9 hours SRT 8.4 
days 
Nakada et al 2006 NO 
 
800 69 
Activated sludge with 
biological nutrient 
removal 
HRT of 6 to 8 hours SRT 8 
to 10 days 
Yu et al 2006 NO 
Trimethoprim 204 40.4 
Activated sludge, 
denitrification and 
nitrification 
HRT of 11.5 hour MLSSconc 
of 2.5 +-0.1 g/L SRT 10 days 
Radjenovic et al 
2009 
Kd 253+-37 L/Kg 
 
140 to 364 -60.7 to 41.2 
Primary treatment, 
activated sludge with 
nitrogen removal and 
sand filtration 
HRT of 24 hours SRT 15 
days 
Lindberg et al 
2005 
Chemical was not 
found in the sludge 
 
1300 to 548 -2.4 to 46.2 
Primary treatment and 
activated sludge with 
nitrogen removal 
HRT of 16 hours SRT 11 
days 
Lindberg et al 
2005 
Chemical was not 
found in the sludge 
 
168+-6.1 ng/L 3 to 14 
Activated sludge, 
denitrification and 
nitrification 
HRT of 15 hours SSconc 
3g/L SRT 10 to 12 days 
Gobel et al 2004, 
2005, 2007 
Kd 208+-49 L/kg 
 
110 +-3.2 ng/L 20 
Activated sludge, 
denitrification and 
nitrification 
HRT of 31 hours SSconc 
3g/L SRT 21 to 25 days 
Gobel et al 2004, 
2005, 2007 
Kd 208+-49 L/kg 
 
260 0 
Chemical precipitation 
with FeCl3 and activated 
sludge 
HRT of 2 to 4 hours 
Morasch & Kohn 
2010 
NO 
105 
 
 
154 23 
Activated sludge, 
denitrification and 
nitrification 
HRT of 16 to 18 hours SRT 
16 to 17 days 
Hollender et al 
2009 
NO 
 
259 to 949 51 
Primary treatment and 
activated sludge 
HRT of 12 hours Lin et al 2009 NO 
 
320 62 
Primary treatment and 
activated sludge 
HRT of 21 hours SRT 20 
days 
Gulkowska et al 
2008 
NO 
 
120 -17 
Primary treatment and 
activated sludge 
HRT of 16 hours SRT 20 
days 
Gulkowska et al 
2008 
NO 
 
53.5 70 
Primary treatment and 
activated sludge 
HRT of 9 hours SRT 8.4 days Nakada et al 2007 NO 
 
1100 69 
Activated sludge, 
biological phosphate 
removal, denitrification 
and nitrification 
HRT of 25 to 35 hours SRT 
12 to 14 days 
Ternes et al 2007 NO 
 
370 91.9 Activated sludge 
HRT of 11 hours SRT 12.5 
days 
Watkinson et al 
2007 
NO 
 
258.7 0 
Trickling filter and 
activated sludge 
HRT of 12.5 hours SRT 2.4 
days 
Roberts and 
Thomas 2006 
NO 
 
 
APPENDIX D: Peer-reviewed metabolic pathways for the 29 TOrCs 
Acetominophen (UM-BBD) 
 
 
Amitriptyline hydrochloride 
 
Adapted from (Kasprzyk-Hordern, Dinsdale et al. 2007) 
107 
 
Androstenedione (UM-BBD)
 
108 
 
Androsterone 
 
M5 compound corresponds to androsterone (Fahrbach, Krauss et al. 2010). 
 
Atenolol 
 
(Radjenovic, Perez et al. 2008) 
 
 
Adapted from (Marco-Urrea, Radjenovic et al. 2010). 
109 
 
Atorvastatin  
 
(Vanderford and Snyder 2006) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
110 
 
Bisphenol A (UM-BBD) 
 
 
 
 
111 
 
Caffeine (UM-BBD) 
 
 
 
 
112 
 
Carbamazephine 
 
(Bernus, Dickinson et al. 1996) 
 
(Mandrioli, Albani et al. 2001) 
113 
 
 
 
 
(Breton, Cociglio et al. 2005) 
114 
 
 
Adapted from (Marco-Urrea, Radjenovic et al. 2010) 
 
 
(Hata, Shintate et al. 2010) 
 
 
 
 
 
 
 
 
 
115 
 
DEET (UM-BBD) 
 
 
 
Diazepam  
 
(Kinani, Bouchonnet et al. 2007) 
116 
 
 
(Acikgöz, Karim et al. 2009) 
 
 
 
 
 
 
117 
 
Diclofenac 
 
(Gröning, Held et al. 2007) 
 
(Marco-Urrea, Pérez-Trujillo et al. 2010) 
 
 
 
 
 
118 
 
Dilantin 
 
Main metabolic pathway on humans 
 
Microsomal oxidation pathway of phenytoin (Yasumori, Chen et al. 1999) 
119 
 
17β-estradiol 
 
(Lee and Liu 2002) 
 
 
 
 
 
 
 
 
 
 
 
120 
 
Estrone, Estriol and 17α-Ethinylestradiol 
 
(Combalbert and Hernandez-Raquet 2010) 
 
(Haiyan and Shulan 2007) 
121 
 
 
 
(Cajthaml, Kresinov et al. 2009) 
 
 
 
Gemfibrozil 
 
(Hermening, Grafe et al. 2000) 
 
122 
 
Ibuprofen 
 
(Mills, Adams et al. 1973) 
 
(Winkler, Lawrence et al. 2001) 
 
(Zwiener, Seeger et al. 2002) 
123 
 
 
(Murdoch and Hay 2005) 
 
(Matamoros, Caselles-Osorio et al. 2008) 
 
 
 
 
 
 
124 
 
Meprobamate 
 
(I) meprobamate, (II) 2-hydroxymethyl-2-propyl-1,3-propanediol dicarbamate, (III) 2-methyl-2-
(β-hydroxypropyl)-1,3-propanediol dicarbamate (Ludwig, Douglas et al. 1960). 
 
 
 
 
 
 
 
 
 
 
 
Adapted from (Calisto and Esteves 2009) 
 
 
 
 
 
125 
 
Naproxen 
 
(Zhong, Sun et al. 2003) 
126 
 
 
(Marco-Urrea, Pérez-Trujillo et al. 2010) 
 
 
 
Phenylphenol (UM-BBD) 
 
 
127 
 
Primidone 
  
(Ferranti, Chabenat et al. 1998) 
 
(Mac Leod, Faria et al. 2008) 
128 
 
Risperidone 
 
(Fang, Bourin et al. 1999) 
 
Sulfamethoxazole 
 
(Trovo, Nogueira et al. 2009) 
129 
 
 
 
 
(Gauthier, Yargeau et al. 2010) 
 
(Wang, Li et al. 2010) 
 
 
 
130 
 
TCEP 
 
This study confirmed chloride ion generation on degradation and the generation of 2-
chloroethanol (2-CE) as metabolite of TCEP. The stable enrichment culture also showed 
dehalogenation ability toward 2-CE and thus the potential ability for complete detoxification of 
the chlorinated compound in the environment. Adapted from (Takahashi, Kawashima et al. 
2008). 
 
Flame retardants, the corresponding metabolites and the internal standards used (Schindler, 
Forster et al. 2009). 
 
 
 
 
 
 
 
 
131 
 
Testosterone (UM-BBD) 
 
Triclosan 
 
(Aranami and Readman 2007) 
132 
 
A       Triclosan     B   Triclosan 
 
Proposed pathway for the catabolism of triclosan by Sphingomonas sp. PH-07. (A) Sequence 
leading to the formation of 3,5-dichlorocatechol. (B) Sequence leading to the formation of 4-
chlorocatechol. Unstable intermediates or metabolites that were not confirmed by mass 
spectrometry are shown in brackets (Kim, Kumarasamy et al. 2010). 
 
133 
 
Trimethoprim 
 
 
The instant decline of the trimethoprim concentration without lag phase was paralleled by the 
concurrent formation of the metabolites M306 and M324, suggesting that both compounds 
were primary degradation products from the direct transformation of the parent drug (Eichhorn, 
Ferguson et al. 2005). 
134 
 
APPENDIX E: Fragments from the MITI Biodegradation Models (Biowin 5 and Biowin 6) 
 
Left graph: fragments present in the 29 TOrCs evaluated in this study. Right graph: fragments 
attacked during the first reaction described on degradation pathways from the literature. 
 
 
ALL FRAGMENTS PRESENT ATTACKED
Al iphatic acid   [-C(=O)-OH]
Al iphatic a lcohol   [-OH]
Al iphatic amine   [-NH2  or  -NH-]
Amide   [-C(=O)-N  or -C(=S)-N]
Aromatic a lcohol   [-OH]
Aromatic amine   [-NH2  or  -NH-]
Aromatic ether  [-O-aromatic carbon]
Aromatic-CH2
Aromatic-CH3
Aromatic-H
C=CH  [a lkenyl  hydrogen]
CH   [cycl ic]
CH  [l inear]
CH2  [cycl ic]
CH2  [l inear]
Ketone   [-C-C(=O)-C-]
Methyl   [-CH3]
Phosphate ester
Tertiary amine
Al iphatic chloride   [-CL]
Aromatic chloride   [-CL]
Aromatic-CH
Carbamate or Thiocarbamate
Carbon with 4 s ingle bonds  & no hydrogens
Fluorine  [-F]
Quaternary amine
Aldehyde   [-CHO]
Al iphatic bromide   [-Br]
Al iphatic ether  [C-O-C]
Aromatic acid   [-C(=O)-OH]
Aromatic bromide   [-Br]
Aromatic iodide   [-I]
Aromatic ni tro  [-NO2]
Azo group   [-N=N-]
Cyanide / Nitri les    [-C#N]
Ester   [-C(=O)-O-C]
Hydrazine  [-N-NH-]
Nitroso   [-N-N=O]
Pyridine ring
Sul fonic acid / sa l t
Tin  [Sn]
Triazine ring (symmetric)
